2012 Tables: Illicit Drug Use - 1.47 to 1.92 (PE), SAMHSA, CBHSQ

130401

Table 1.47A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	15,540	16,563	541	573	257	182
GENDER
Male	10,507	11,460	448	490	223	171
Female	5,033	5,104	93	83	35	11
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14,186	15,224	518	440	251	162
White	13,030	14,015	412	341	203	119
Black or African American	527	600	28	20	27	20
American Indian or Alaska Native	74	97	*	10	*	*
Native Hawaiian or Other Pacific Islander	*	15	*	2	*	*
Asian	172	313	31	49	10	8
Two or More Races	330^a	184	20	17	7	9
Hispanic or Latino	1,354	1,340	23	133	6	20
EDUCATION
< High School	1,649	1,847	79	32	69	24
High School Graduate	3,635	3,999	94	98	41	10
Some College	4,272	4,389	131	116	74	57
College Graduate	5,985	6,329	237	328	74	91
CURRENT EMPLOYMENT
Full-Time	9,831	10,412	285	383	142	105
Part-Time	1,987	2,145	6	56	*	26
Unemployed	1,060	1,000	82	69	20	*
Other¹	2,662	3,007	167	65	95^a	14

130401

Table 1.47B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	7.8	8.3	0.3	0.3	0.1	0.1
GENDER
Male	11.1	12.0	0.5	0.5	0.2	0.2
Female	4.9	4.9	0.1	0.1	0.0	0.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.3	8.8	0.3	0.3	0.1	0.1
White	9.6	10.3	0.3	0.3	0.1	0.1
Black or African American	2.4	2.7	0.1	0.1	0.1	0.1
American Indian or Alaska Native	6.8	9.5	*	1.0	*	*
Native Hawaiian or Other Pacific Islander	*	1.9	*	0.3	*	*
Asian	1.8	3.2	0.3	0.5	0.1	0.1
Two or More Races	12.8^a	6.9	0.8	0.7	0.3	0.3
Hispanic or Latino	5.0	4.8	0.1	0.5	0.0	0.1
EDUCATION
< High School	6.0	6.4	0.3	0.1	0.3	0.1
High School Graduate	6.3	6.9	0.2	0.2	0.1	0.0
Some College	8.6	8.7	0.3	0.2	0.1	0.1
College Graduate	9.5	10.0	0.4	0.5	0.1	0.1
CURRENT EMPLOYMENT
Full-Time	9.5	10.0	0.3	0.4	0.1	0.1
Part-Time	8.6	9.2	0.0	0.2	*	0.1
Unemployed	11.6	10.6	0.9	0.7	0.2	*
Other¹	4.2	4.7	0.3	0.1	0.2^a	0.0

130401

Table 1.48A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	18,646	19,482	1,041	1,046	402	305
GENDER
Male	12,305	13,204	750	780	320	249
Female	6,341	6,278	291	265	82	55
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	16,743	17,629	927	844	367	266
White	15,214	16,019	736	674	282	194
Black or African American	700	771	63	67	38	41
American Indian or Alaska Native	102	135	*	12	*	*
Native Hawaiian or Other Pacific Islander	68	36	12	2	12	*
Asian	269	395	65	54	27	9
Two or More Races	390	273	28	33	7	16
Hispanic or Latino	1,903	1,853	113	202	35	38
EDUCATION
< High School	2,214	2,344	162	132	91	51
High School Graduate	4,692	5,008	255	266	75	52
Some College	5,325	5,441	349	279	146	100
College Graduate	6,416	6,689	275	370	90	101
CURRENT EMPLOYMENT
Full-Time	11,015	11,593	418	539	161	141
Part-Time	2,886	2,990	146	231	33	84
Unemployed	1,523	1,371	180	119	50	45
Other¹	3,222	3,528	297^a	156	158^b	34

130401

Table 1.48B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	8.0	8.3	0.4	0.4	0.2	0.1
GENDER
Male	11.0	11.7	0.7	0.7	0.3	0.2
Female	5.3	5.1	0.2	0.2	0.1	0.0
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.4	8.8	0.5	0.4	0.2	0.1
White	9.8	10.3	0.5	0.4	0.2	0.1
Black or African American	2.6	2.8	0.2	0.2	0.1	0.2
American Indian or Alaska Native	7.9	10.4	*	0.9	*	*
Native Hawaiian or Other Pacific Islander	7.9	3.7	1.4	0.2	1.4	*
Asian	2.4	3.4	0.6	0.5	0.2	0.1
Two or More Races	11.9	8.0	0.9	1.0	0.2	0.5
Hispanic or Latino	5.6	5.3	0.3	0.6	0.1	0.1
EDUCATION
< High School	6.7	6.8	0.5	0.4	0.3	0.2
High School Graduate	6.7	7.2	0.4	0.4	0.1	0.1
Some College	8.6	8.7	0.6	0.4	0.2	0.2
College Graduate	9.4	9.8	0.4	0.5	0.1	0.1
CURRENT EMPLOYMENT
Full-Time	9.5	9.9	0.4	0.5	0.1	0.1
Part-Time	8.9	9.1	0.5	0.7	0.1	0.3
Unemployed	11.2	10.1	1.3	0.9	0.4	0.3
Other¹	4.5	5.0	0.4^a	0.2	0.2^b	0.0

130401

Table 1.49A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	51,243^b	54,389	14,657^b	16,666	6,119^a	6,831
AGE
12-17	2,522	2,482	1,749	1,642	688	693
18-25	9,373	9,709	4,366^a	4,729	1,711	1,832
26 or Older	39,348^b	42,198	8,542^b	10,296	3,720	4,306
GENDER
Male	27,317^a	29,080	7,676^b	8,663	3,229	3,565
Female	23,926^a	25,309	6,981^b	8,003	2,891	3,266
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	45,349	46,859	12,503^b	13,970	5,255	5,845
White	38,737	39,534	10,506	11,296	4,399	4,790
Black or African American	4,168	4,497	1,273^b	1,810	498^a	720
American Indian or Alaska Native	366	419	161	158	85	67
Native Hawaiian or Other Pacific Islander	*	204	47	44	35	14
Asian	880	1,219	251	376	111	154
Two or More Races	978	987	266	286	127	99
Hispanic or Latino	5,894^b	7,530	2,154^a	2,696	864	985

130401

Table 1.49B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	19.9^a	20.9	5.7^b	6.4	2.4	2.6
AGE
12-17	10.1	10.0	7.0	6.6	2.8	2.8
18-25	27.3	28.1	12.7^a	13.7	5.0	5.3
26 or Older	19.8^a	21.0	4.3^b	5.1	1.9	2.1
GENDER
Male	21.9	23.1	6.2^a	6.9	2.6	2.8
Female	18.0	18.9	5.2^b	6.0	2.2	2.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	20.8	21.3	5.7^b	6.4	2.4	2.7
White	22.9	23.3	6.2	6.7	2.6	2.8
Black or African American	13.8	14.6	4.2^b	5.9	1.6^a	2.3
American Indian or Alaska Native	25.6	29.0	11.3	10.9	6.0	4.7
Native Hawaiian or Other Pacific Islander	*	18.9	5.0	4.1	3.7	1.3
Asian	7.1	9.5	2.0	2.9	0.9	1.2
Two or More Races	24.5	23.8	6.7	6.9	3.2	2.4
Hispanic or Latino	15.0^b	18.7	5.5^a	6.7	2.2	2.4

130401

Table 1.50A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	2,522	2,482	1,749	1,642	688	693
GENDER
Male	1,215	1,209	829	777	302	308
Female	1,307	1,273	920	865	386	385
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,972	1,938	1,387	1,315	554	558
White	1,425	1,390	1,036	965	405	406
Black or African American	356	362	223	240	89	104
American Indian or Alaska Native	23	19	20	11	10	7
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	58	49	33	24	14	12
Two or More Races	98	97	72	68	35	28
Hispanic or Latino	551	544	362	327	134	135
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic	705	669	500	451	185	186
Female, White, Not Hispanic	720	722	535	514	220	220
Male, Black, Not Hispanic	168	178	109	111	33	34
Female, Black, Not Hispanic	188	184	114	129	56	70
Male, Hispanic	257	265	167	166	54	66
Female, Hispanic	294	279	195	161	79	69

130401

Table 1.50B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	10.1	10.0	7.0	6.6	2.8	2.8
GENDER
Male	9.5	9.5	6.5	6.1	2.4	2.4
Female	10.7	10.4	7.5	7.1	3.2	3.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	10.1	10.0	7.1	6.8	2.8	2.9
White	10.3	10.1	7.5	7.0	2.9	3.0
Black or African American	10.1	10.3	6.3	6.8	2.5	3.0
American Indian or Alaska Native	16.9	12.8	14.3	7.4	7.6	4.7
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	4.8	4.2	2.7	2.0	1.1	1.0
Two or More Races	13.7	13.2	10.1	9.3	4.9	3.8
Hispanic or Latino	10.2	9.9	6.7	5.9	2.5	2.5
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic	9.9	9.5	7.0	6.4	2.6	2.6
Female, White, Not Hispanic	10.7	10.8	7.9	7.7	3.3	3.3
Male, Black, Not Hispanic	9.5	10.0	6.2	6.2	1.9	1.9
Female, Black, Not Hispanic	10.6	10.6	6.4	7.4	3.2	4.0
Male, Hispanic	9.3	9.4	6.0	5.9	2.0	2.4
Female, Hispanic	11.1	10.4	7.4	6.0	3.0	2.6

130401

Table 1.51A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	9,373	9,709	4,366^a	4,729	1,711	1,832
GENDER
Male	4,996	5,093	2,442	2,517	945	917
Female	4,377	4,616	1,924^b	2,212	766^a	915
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	7,852	8,083	3,686^a	4,013	1,494	1,548
White	6,470	6,541	3,054	3,195	1,236	1,241
Black or African American	814	884	387	475	148	186
American Indian or Alaska Native	85	*	34	*	9	12
Native Hawaiian or Other Pacific Islander	*	*	*	14	*	7
Asian	245	242	91	127	37	58
Two or More Races	193^a	282	102	131	50	43
Hispanic or Latino	1,520	1,626	680	716	217	285
EDUCATION
< High School	1,614	1,603	766	803	351	325
High School Graduate	3,111	3,194	1,540	1,622	603	693
Some College	3,410	3,493	1,590	1,703	602	644
College Graduate	1,237^a	1,419	471^a	600	154	171
CURRENT EMPLOYMENT
Full-Time	3,680^b	4,106	1,565^a	1,796	544^b	729
Part-Time	2,553	2,622	1,228	1,281	497	457
Unemployed	1,340	1,282	674	726	317	328
Other¹	1,799	1,699	899	926	353	318

130401

Table 1.51B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	27.3	28.1	12.7^a	13.7	5.0	5.3
GENDER
Male	29.1	29.4	14.2	14.5	5.5	5.3
Female	25.6	26.8	11.2^b	12.8	4.5^a	5.3
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	28.8	29.4	13.5^a	14.6	5.5	5.6
White	33.0	33.5	15.6	16.3	6.3	6.4
Black or African American	17.3	18.0	8.2	9.7	3.1	3.8
American Indian or Alaska Native	39.7	*	15.9	*	4.4	4.5
Native Hawaiian or Other Pacific Islander	*	*	*	7.4	*	3.9
Asian	13.0	13.6	4.8	7.1	2.0	3.2
Two or More Races	27.2^b	37.1	14.4	17.2	7.1	5.7
Hispanic or Latino	21.6	22.8	9.6	10.0	3.1	4.0
EDUCATION
< High School	28.1	30.1	13.3	15.1	6.1	6.1
High School Graduate	26.6	27.1	13.2	13.8	5.2	5.9
Some College	28.5	28.3	13.3	13.8	5.0	5.2
College Graduate	25.2	27.7	9.6^a	11.7	3.1	3.3
CURRENT EMPLOYMENT
Full-Time	29.5	30.5	12.5	13.3	4.4^a	5.4
Part-Time	27.3	27.9	13.1	13.6	5.3	4.9
Unemployed	29.9	31.2	15.0^a	17.7	7.1	8.0
Other¹	22.6	22.3	11.3	12.2	4.4	4.2

130401

Table 1.52A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	39,348^b	42,198	8,542^b	10,296	3,720	4,306
GENDER
Male	21,106^a	22,778	4,406^b	5,369	1,981	2,340
Female	18,241	19,420	4,136^a	4,927	1,739	1,966
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	35,525	36,839	7,431^b	8,642	3,207	3,740
White	30,843	31,602	6,416	7,136	2,758	3,143
Black or African American	2,999	3,250	663^a	1,095	261^a	430
American Indian or Alaska Native	257	303	107	76	65	48
Native Hawaiian or Other Pacific Islander	*	*	*	23	*	6
Asian	577^a	928	127	225	60	85
Two or More Races	687	608	91	87	42	28
Hispanic or Latino	3,823^b	5,360	1,111^b	1,654	513	566
EDUCATION
< High School	4,521^a	5,419	1,356	1,650	743	647
High School Graduate	10,478	11,204	2,449	2,907	1,150	1,295
Some College	11,816	12,103	2,383^a	3,076	1,023	1,143
College Graduate	12,533	13,473	2,355	2,662	805^a	1,220
CURRENT EMPLOYMENT
Full-Time	23,094^b	25,595	4,789^b	6,039	2,035	2,410
Part-Time	4,957	5,090	1,234	1,250	483	611
Unemployed	2,522	2,765	779	864	338	478
Other¹	8,775	8,748	1,740	2,143	864	807

130401

Table 1.52B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	19.8^a	21.0	4.3^b	5.1	1.9	2.1
GENDER
Male	22.3	23.8	4.7^a	5.6	2.1	2.4
Female	17.6	18.5	4.0^a	4.7	1.7	1.9
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	20.7	21.3	4.3^a	5.0	1.9	2.2
White	22.7	23.2	4.7	5.2	2.0	2.3
Black or African American	13.6	14.6	3.0^a	4.9	1.2^a	1.9
American Indian or Alaska Native	23.9	29.4	10.0	7.4	6.1	4.7
Native Hawaiian or Other Pacific Islander	*	*	*	2.9	*	0.8
Asian	6.2	9.4	1.4	2.3	0.6	0.9
Two or More Races	26.7	22.9	3.6	3.3	1.6	1.1
Hispanic or Latino	14.2^b	19.4	4.1^a	6.0	1.9	2.0
EDUCATION
< High School	16.6	18.7	5.0	5.7	2.7	2.2
High School Graduate	18.1	19.3	4.2	5.0	2.0	2.2
Some College	23.8	24.1	4.8^a	6.1	2.1	2.3
College Graduate	19.8	21.2	3.7	4.2	1.3^a	1.9
CURRENT EMPLOYMENT
Full-Time	22.4^b	24.6	4.6^b	5.8	2.0	2.3
Part-Time	21.5	21.8	5.4	5.3	2.1	2.6
Unemployed	27.7	29.2	8.5	9.1	3.7	5.0
Other¹	14.0	13.8	2.8	3.4	1.4	1.3

130401

Table 1.53A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	48,721^b	51,908	12,908^b	15,025	5,431^a	6,138
GENDER
Male	26,102^a	27,872	6,848^b	7,886	2,926	3,257
Female	22,618^a	24,036	6,060^b	7,139	2,505	2,881
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	43,377	44,922	11,116^b	12,655	4,701	5,288
White	37,313	38,144	9,470	10,331	3,993	4,384
Black or African American	3,813	4,134	1,050^b	1,569	409^a	616
American Indian or Alaska Native	343	400	142	147	75	60
Native Hawaiian or Other Pacific Islander	*	*	43	37	34	13
Asian	822^a	1,169	218	352	98	142
Two or More Races	881	890	194	218	92	72
Hispanic or Latino	5,344^b	6,986	1,791^b	2,370	730	850
EDUCATION
< High School	6,135^a	7,022	2,122	2,454	1,094	972
High School Graduate	13,589	14,398	3,988	4,530	1,753	1,988
Some College	15,226	15,596	3,972^b	4,779	1,625	1,787
College Graduate	13,770	14,892	2,825	3,262	959^a	1,391
CURRENT EMPLOYMENT
Full-Time	26,774^b	29,701	6,354^b	7,834	2,580^a	3,140
Part-Time	7,510	7,712	2,462	2,531	980	1,067
Unemployed	3,862	4,047	1,452	1,590	655	806
Other¹	10,574	10,447	2,639	3,069	1,217	1,125

130401

Table 1.53B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	20.9^a	22.1	5.5^b	6.4	2.3	2.6
GENDER
Male	23.3	24.6	6.1^a	7.0	2.6	2.9
Female	18.7	19.7	5.0^b	5.9	2.1	2.4
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	21.8	22.4	5.6^b	6.3	2.4	2.6
White	24.0	24.5	6.1	6.6	2.6	2.8
Black or African American	14.3	15.2	3.9^b	5.8	1.5^a	2.3
American Indian or Alaska Native	26.6	30.9	11.0	11.3	5.8	4.7
Native Hawaiian or Other Pacific Islander	*	*	5.0	3.7	3.9	1.4
Asian	7.3	10.1	1.9	3.0	0.9	1.2
Two or More Races	26.9	26.0	5.9	6.4	2.8	2.1
Hispanic or Latino	15.7^b	20.1	5.3^a	6.8	2.1	2.4
EDUCATION
< High School	18.6	20.5	6.4	7.2	3.3	2.8
High School Graduate	19.5	20.7	5.7	6.5	2.5	2.9
Some College	24.7	24.9	6.4^a	7.6	2.6	2.9
College Graduate	20.2	21.7	4.1	4.8	1.4^a	2.0
CURRENT EMPLOYMENT
Full-Time	23.1^b	25.2	5.5^b	6.7	2.2^a	2.7
Part-Time	23.2	23.5	7.6	7.7	3.0	3.3
Unemployed	28.4	29.8	10.7	11.7	4.8	5.9
Other¹	14.9	14.7	3.7	4.3	1.7	1.6

130401

Table 1.54A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	34,247^b	37,045	11,143^b	12,489	4,471	4,862
AGE
12-17	2,150	2,069	1,484^a	1,333	563	558
18-25	7,600	7,759	3,353	3,507	1,220	1,311
26 or Older	24,497^b	27,218	6,306^b	7,649	2,688	2,993
GENDER
Male	19,338^a	20,826	6,037^a	6,851	2,530	2,646
Female	14,908^a	16,219	5,106	5,638	1,940	2,216
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	29,994^a	31,771	9,435^a	10,439	3,838	4,179
White	25,152	26,237	7,803	8,181	3,149	3,306
Black or African American	3,284	3,587	1,069^b	1,599	433^a	615
American Indian or Alaska Native	217	266	115	113	66	56
Native Hawaiian or Other Pacific Islander	106	*	26	33	11	4
Asian	627	809	213	294	79	116
Two or More Races	608	711	209	218	101	82
Hispanic or Latino	4,252^b	5,274	1,708	2,051	632	683

130401

Table 1.54B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	13.3^b	14.2	4.3^b	4.8	1.7	1.9
AGE
12-17	8.6	8.3	5.9^a	5.3	2.3	2.2
18-25	22.2	22.4	9.8	10.1	3.6	3.8
26 or Older	12.4^b	13.6	3.2^b	3.8	1.4	1.5
GENDER
Male	15.5^a	16.5	4.8^a	5.4	2.0	2.1
Female	11.2^a	12.1	3.8	4.2	1.5	1.7
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	13.7^a	14.5	4.3^a	4.8	1.8	1.9
White	14.9	15.5	4.6	4.8	1.9	1.9
Black or African American	10.8	11.7	3.5^b	5.2	1.4^a	2.0
American Indian or Alaska Native	15.2	18.4	8.1	7.8	4.6	3.9
Native Hawaiian or Other Pacific Islander	11.3	*	2.8	3.1	1.2	0.4
Asian	5.0	6.3	1.7	2.3	0.6	0.9
Two or More Races	15.2	17.1	5.2	5.3	2.5	2.0
Hispanic or Latino	10.8^b	13.1	4.3	5.1	1.6	1.7

130401

Table 1.55A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	2,150	2,069	1,484^a	1,333	563	558
GENDER
Male	1,027	1,029	693	653	244	250
Female	1,123	1,040	791^a	680	319	308
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	1,675	1,612	1,173^a	1,053	447	445
White	1,203	1,136	868^a	754	317	317
Black or African American	305	324	194	212	84	89
American Indian or Alaska Native	18	17	16	8	6	4
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	49	35	27	17	12	9
Two or More Races	88	85	64	55	27	25
Hispanic or Latino	475	456	311	280	116	113
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic	605	562	427	368	144	151
Female, White, Not Hispanic	599	575	441	386	174	166
Male, Black, Not Hispanic	141	160	93	102	32	29
Female, Black, Not Hispanic	165	165	101	110	52	59
Male, Hispanic	207	226	127	140	48	54
Female, Hispanic	268	230	183	140	68	60

130401

Table 1.55B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	8.6	8.3	5.9^a	5.3	2.3	2.2
GENDER
Male	8.0	8.1	5.4	5.1	1.9	2.0
Female	9.2	8.5	6.5^a	5.6	2.6	2.5
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	8.6	8.3	6.0^a	5.4	2.3	2.3
White	8.7	8.3	6.3^a	5.5	2.3	2.3
Black or African American	8.6	9.2	5.5	6.0	2.4	2.5
American Indian or Alaska Native	13.4	11.5	11.9	5.3	4.6	3.0
Native Hawaiian or Other Pacific Islander	*	*	*	*	*	*
Asian	4.0	3.0	2.2	1.4	1.0	0.8
Two or More Races	12.2	11.6	9.0	7.6	3.8	3.4
Hispanic or Latino	8.8	8.3	5.7	5.1	2.1	2.1
GENDER/RACE/HISPANIC ORIGIN
Male, White, Not Hispanic	8.5	8.0	6.0	5.2	2.0	2.1
Female, White, Not Hispanic	8.9	8.6	6.5	5.8	2.6	2.5
Male, Black, Not Hispanic	8.0	8.9	5.3	5.7	1.8	1.6
Female, Black, Not Hispanic	9.3	9.5	5.7	6.3	2.9	3.4
Male, Hispanic	7.5	8.1	4.6	5.0	1.7	1.9
Female, Hispanic	10.1	8.6	6.9	5.2	2.6	2.2

130401

Table 1.56A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	7,600	7,759	3,353	3,507	1,220	1,311
GENDER
Male	4,175	4,245	1,888	1,898	705	685
Female	3,425	3,514	1,465	1,609	515	626
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	6,409	6,499	2,811	2,994	1,072	1,114
White	5,229	5,173	2,290	2,345	871	860
Black or African American	721	796	336	412	129	162
American Indian or Alaska Native	69	57	27	33	9	10
Native Hawaiian or Other Pacific Islander	*	*	*	9	*	2
Asian	200	182	67	100	22	46
Two or More Races	159^b	261	79	96	34	33
Hispanic or Latino	1,191	1,259	542	513	148	197
EDUCATION
< High School	1,368	1,354	648	625	277	258
High School Graduate	2,646	2,701	1,258	1,306	448	525
Some College	2,677	2,730	1,115	1,236	391	438
College Graduate	910	974	332	340	104	90
CURRENT EMPLOYMENT
Full-Time	3,002^a	3,338	1,245	1,397	429^a	551
Part-Time	2,028	2,016	891	909	331	288
Unemployed	1,141	1,085	560	581	246	260
Other¹	1,430	1,320	657	620	213	211

130401

Table 1.56B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	22.2	22.4	9.8	10.1	3.6	3.8
GENDER
Male	24.3	24.5	11.0	10.9	4.1	4.0
Female	20.0	20.4	8.6	9.3	3.0	3.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	23.5	23.7	10.3	10.9	3.9	4.1
White	26.7	26.5	11.7	12.0	4.4	4.4
Black or African American	15.4	16.2	7.2	8.4	2.7	3.3
American Indian or Alaska Native	31.8	21.4	12.6	12.3	4.0	3.8
Native Hawaiian or Other Pacific Islander	*	*	*	4.5	*	1.2
Asian	10.6	10.2	3.6	5.6	1.2	2.6
Two or More Races	22.5^b	34.2	11.1	12.6	4.8	4.4
Hispanic or Latino	16.9	17.6	7.7	7.2	2.1	2.8
EDUCATION
< High School	23.8	25.4	11.3	11.7	4.8	4.9
High School Graduate	22.6	22.9	10.8	11.1	3.8	4.5
Some College	22.4	22.1	9.3	10.0	3.3	3.5
College Graduate	18.6	19.0	6.8	6.6	2.1	1.7
CURRENT EMPLOYMENT
Full-Time	24.0	24.8	10.0	10.4	3.4	4.1
Part-Time	21.6	21.5	9.5	9.7	3.5	3.1
Unemployed	25.4	26.4	12.5	14.1	5.5	6.3
Other¹	18.0	17.3	8.3	8.1	2.7	2.8

130401

Table 1.57A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	24,497^b	27,218	6,306^b	7,649	2,688	2,993
GENDER
Male	14,136^a	15,553	3,456^a	4,300	1,581	1,711
Female	10,361^b	11,665	2,850	3,349	1,107	1,282
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	21,911^a	23,659	5,451^a	6,392	2,319	2,620
White	18,720	19,927	4,645	5,083	1,961	2,129
Black or African American	2,258	2,467	539^a	975	220	364
American Indian or Alaska Native	130	192	72	72	51	42
Native Hawaiian or Other Pacific Islander	*	*	*	18	*	1
Asian	379	592	119	177	45	60
Two or More Races	361	365	65	67	39	23
Hispanic or Latino	2,586^b	3,559	855^a	1,257	369	373
EDUCATION
< High School	3,147^a	3,791	1,062	1,404	576	496
High School Graduate	6,946	7,785	1,901	2,163	920	895
Some College	7,388	8,212	1,759^a	2,383	690	810
College Graduate	7,015	7,429	1,584	1,699	502^a	791
CURRENT EMPLOYMENT
Full-Time	14,597^b	16,690	3,756^a	4,501	1,570	1,734
Part-Time	2,942	3,143	844	893	282	397
Unemployed	1,783	2,075	495	667	228	333
Other¹	5,174	5,310	1,210	1,589	607	530

130401

Table 1.57B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	12.4^b	13.6	3.2^b	3.8	1.4	1.5
GENDER
Male	14.9^a	16.2	3.6^a	4.5	1.7	1.8
Female	10.0^a	11.1	2.8	3.2	1.1	1.2
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	12.8^a	13.7	3.2^a	3.7	1.4	1.5
White	13.8	14.6	3.4	3.7	1.4	1.6
Black or African American	10.2	11.1	2.4^a	4.4	1.0	1.6
American Indian or Alaska Native	12.1	18.7	6.7	7.0	4.8	4.0
Native Hawaiian or Other Pacific Islander	*	*	*	2.3	*	0.2
Asian	4.1	6.0	1.3	1.8	0.5	0.6
Two or More Races	14.0	13.7	2.5	2.5	1.5	0.9
Hispanic or Latino	9.6^b	12.9	3.2^a	4.5	1.4	1.3
EDUCATION
< High School	11.5	13.1	3.9	4.9	2.1	1.7
High School Graduate	12.0^a	13.4	3.3	3.7	1.6	1.5
Some College	14.9	16.4	3.5^a	4.7	1.4	1.6
College Graduate	11.1	11.7	2.5	2.7	0.8^a	1.2
CURRENT EMPLOYMENT
Full-Time	14.1^b	16.0	3.6^a	4.3	1.5	1.7
Part-Time	12.8	13.4	3.7	3.8	1.2	1.7
Unemployed	19.6	21.9	5.4	7.0	2.5	3.5
Other¹	8.2	8.4	1.9	2.5	1.0	0.8

130401

Table 1.58A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	32,097^b	34,977	9,659^b	11,157	3,908	4,304
GENDER
Male	18,311^a	19,797	5,344^a	6,198	2,286	2,396
Female	13,786^b	15,179	4,315^a	4,958	1,622	1,908
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	28,319^a	30,158	8,262^b	9,386	3,391	3,734
White	23,949	25,100	6,935	7,428	2,832	2,989
Black or African American	2,979	3,263	875^b	1,387	349^a	527
American Indian or Alaska Native	199	249	99	105	60	52
Native Hawaiian or Other Pacific Islander	94	*	22	27	11	4
Asian	578	774	186	277	67	107
Two or More Races	520	625	145	163	73	57
Hispanic or Latino	3,777^b	4,818	1,397	1,771	517	570
EDUCATION
< High School	4,515	5,145	1,710	2,029	852	755
High School Graduate	9,592	10,486	3,159	3,470	1,368	1,420
Some College	10,065	10,943	2,875^b	3,619	1,081	1,248
College Graduate	7,925	8,403	1,916	2,040	606^a	881
CURRENT EMPLOYMENT
Full-Time	17,599^b	20,027	5,001^b	5,898	2,000	2,285
Part-Time	4,970	5,159	1,735	1,802	614	685
Unemployed	2,923	3,160	1,055	1,248	475	593
Other¹	6,605	6,630	1,868	2,209	820	741

130401

Table 1.58B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2011 and 2012
Demographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	13.8^b	14.9	4.2^b	4.7	1.7	1.8
GENDER
Male	16.4^a	17.5	4.8^a	5.5	2.0	2.1
Female	11.4^a	12.4	3.6^a	4.1	1.3	1.6
HISPANIC ORIGIN AND RACE
Not Hispanic or Latino	14.3^a	15.1	4.2^b	4.7	1.7	1.9
White	15.4	16.1	4.5	4.8	1.8	1.9
Black or African American	11.1	12.0	3.3^b	5.1	1.3^a	1.9
American Indian or Alaska Native	15.4	19.2	7.7	8.1	4.6	4.0
Native Hawaiian or Other Pacific Islander	10.9	*	2.6	2.7	1.3	0.4
Asian	5.2	6.7	1.7	2.4	0.6	0.9
Two or More Races	15.9	18.3	4.4	4.8	2.2	1.7
Hispanic or Latino	11.1^b	13.8	4.1	5.1	1.5	1.6
EDUCATION
< High School	13.7	15.0	5.2	5.9	2.6	2.2
High School Graduate	13.8^a	15.0	4.5	5.0	2.0	2.0
Some College	16.3	17.5	4.7^b	5.8	1.8	2.0
College Graduate	11.6	12.3	2.8	3.0	0.9^a	1.3
CURRENT EMPLOYMENT
Full-Time	15.2^b	17.0	4.3^a	5.0	1.7	1.9
Part-Time	15.3	15.7	5.3	5.5	1.9	2.1
Unemployed	21.5	23.3	7.8	9.2	3.5	4.4
Other¹	9.3	9.3	2.6	3.1	1.2	1.0

130328

Table 1.59A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	121,078^b	124,808	38,287^b	41,479	22,454^a	23,863
GEOGRAPHIC DIVISION
Northeast	22,550	23,047	7,263	7,808	4,319	4,527
New England	6,598	6,879	2,190	2,314	1,273	1,420
Middle Atlantic	15,952	16,168	5,073	5,494	3,046	3,107
Midwest	26,283	27,070	7,839^a	8,602	4,738	4,797
East North Central	18,453^a	19,440	5,725^a	6,401	3,568	3,665
West North Central	7,830	7,630	2,114	2,201	1,170	1,132
South	42,916	43,696	12,753	13,575	7,114	7,456
South Atlantic	23,350	24,180	6,871	7,266	3,716	4,217
East South Central	6,826	6,496	1,977	1,986	1,239	1,039
West South Central	12,741	13,020	3,905	4,323	2,159	2,200
West	29,329^a	30,995	10,432^a	11,495	6,283^a	7,083
Mountain	9,109	9,619	2,947	3,284	1,653	1,894
Pacific	20,219	21,376	7,486	8,211	4,630	5,189
COUNTY TYPE
Large Metro	65,728	67,668	21,427^b	23,815	12,572^a	13,724
Small Metro	38,181	38,944	11,965	12,388	7,007	7,250
250K - 1 Mil. Pop.	26,052	26,311	8,038	8,354	4,740	4,897
< 250K Pop.	12,129	12,634	3,927	4,035	2,267	2,353
Nonmetro	17,169	18,196	4,894	5,276	2,875	2,889
Urbanized	7,840	8,700	2,413	2,685	1,431	1,532
Less Urbanized	7,608	7,637	2,047	2,184	1,206	1,128
Completely Rural	1,721	1,860	434	407	238	229

130328

Table 1.59B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	47.0	48.0	14.9^b	16.0	8.7	9.2
GEOGRAPHIC DIVISION
Northeast	48.1	48.9	15.5	16.6	9.2	9.6
New England	53.5	55.4	17.8	18.6	10.3	11.4
Middle Atlantic	46.1	46.5	14.7	15.8	8.8	8.9
Midwest	47.2	48.4	14.1^a	15.4	8.5	8.6
East North Central	47.7^a	50.1	14.8^a	16.5	9.2	9.4
West North Central	46.1	44.6	12.4	12.9	6.9	6.6
South	45.1	45.3	13.4	14.1	7.5	7.7
South Atlantic	46.5	47.5	13.7	14.3	7.4	8.3
East South Central	44.6	42.2	12.9	12.9	8.1	6.7
West South Central	42.9	43.2	13.2	14.4	7.3	7.3
West	49.0	51.2	17.4^a	19.0	10.5	11.7
Mountain	50.2	52.2	16.2	17.8	9.1	10.3
Pacific	48.5	50.7	18.0	19.5	11.1	12.3
COUNTY TYPE
Large Metro	48.0	48.6	15.7^b	17.1	9.2	9.9
Small Metro	47.4^b	49.6	14.8	15.8	8.7	9.2
250K - 1 Mil. Pop.	47.8	49.7	14.7	15.8	8.7	9.3
< 250K Pop.	46.5^a	49.3	15.0	15.8	8.7	9.2
Nonmetro	42.7	43.1	12.2	12.5	7.2	6.8
Urbanized	46.7	47.1	14.4	14.5	8.5	8.3
Less Urbanized	39.7	40.2	10.7	11.5	6.3	5.9
Completely Rural	41.0	39.0	10.3	8.5	5.7	4.8

130328

Table 1.60A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	6,373^a	6,044	4,735^a	4,468	2,522	2,377
GEOGRAPHIC DIVISION
Northeast	1,110^a	979	854^a	743	442	398
New England	307	273	250	224	138	128
Middle Atlantic	803^a	706	605	518	304	270
Midwest	1,304	1,285	960	951	511	512
East North Central	910	924	663	682	368	366
West North Central	395	361	297	269	144	145
South	2,209	2,258	1,585	1,655	831	849
South Atlantic	1,087	1,182	781	870	393	462
East South Central	336	330	240	226	139^a	104
West South Central	786	746	563	559	298	283
West	1,749^b	1,523	1,336^b	1,120	738^a	617
Mountain	511	494	390	364	215	218
Pacific	1,238^b	1,029	946^b	756	523^b	399
COUNTY TYPE
Large Metro	3,403	3,312	2,521	2,480	1,314	1,295
Small Metro	2,013^a	1,815	1,507^a	1,330	864^b	716
250K - 1 Mil. Pop.	1,398^a	1,234	1,076^a	922	600	514
< 250K Pop.	615	581	432	408	265^a	202
Nonmetro	957	917	707	658	344	365
Urbanized	445	446	351	315	174	169
Less Urbanized	423	379	293	269	141	149
Completely Rural	89	92	63	74	28	48

130328

Table 1.60B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	25.5^a	24.2	19.0^a	17.9	10.1	9.5
GEOGRAPHIC DIVISION
Northeast	25.9^a	23.1	20.0^a	17.5	10.3	9.4
New England	27.6	24.8	22.4	20.3	12.4	11.6
Middle Atlantic	25.4^a	22.5	19.1	16.5	9.6	8.6
Midwest	24.0	23.7	17.6	17.6	9.4	9.4
East North Central	23.9	24.4	17.4	18.0	9.7	9.7
West North Central	24.1	22.0	18.2	16.5	8.8	8.9
South	23.9	24.3	17.1	17.8	9.0	9.1
South Atlantic	23.5	25.5	16.9	18.7	8.5	10.0
East South Central	22.8	22.3	16.2	15.3	9.4^a	7.1
West South Central	24.9	23.4	17.8	17.5	9.4	8.9
West	29.2^b	25.5	22.3^b	18.7	12.3^a	10.3
Mountain	27.8	26.6	21.2	19.6	11.7	11.8
Pacific	29.8^b	25.0	22.8^b	18.4	12.6^a	9.7
COUNTY TYPE
Large Metro	25.6	24.4	18.9	18.2	9.9	9.5
Small Metro	25.7	24.5	19.2	17.9	11.0^a	9.7
250K - 1 Mil. Pop.	26.1	24.1	20.0^a	18.0	11.2	10.1
< 250K Pop.	24.9	25.3	17.5	17.8	10.7	8.8
Nonmetro	25.0	23.4	18.5	16.8	9.0	9.3
Urbanized	26.3	24.6	20.7	17.4	10.3	9.3
Less Urbanized	23.9	22.4	16.6	15.9	8.0	8.8
Completely Rural	24.9	22.1	17.6	17.9	7.8	11.5

130328

Table 1.61A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	19,534	19,977	12,067^a	12,551	7,352	7,381
GEOGRAPHIC DIVISION
Northeast	3,540	3,692	2,332^a	2,535	1,410	1,528
New England	1,007	1,048	701	739	446	460
Middle Atlantic	2,533	2,643	1,631^a	1,796	964	1,068
Midwest	4,168	4,255	2,537	2,587	1,513	1,478
East North Central	2,939	2,984	1,792	1,814	1,084	1,121
West North Central	1,229	1,271	745	773	429	357
South	6,999	7,040	4,094	4,228	2,442	2,385
South Atlantic	3,738	3,666	2,269	2,288	1,374	1,350
East South Central	1,091	1,087	623	623	376	351
West South Central	2,169	2,288	1,202	1,317	692	684
West	4,827	4,989	3,103	3,201	1,987	1,991
Mountain	1,498	1,512	885	922	534	556
Pacific	3,330	3,477	2,219	2,280	1,453	1,435
COUNTY TYPE
Large Metro	10,500^a	11,244	6,708^a	7,295	4,179	4,420
Small Metro	6,417	6,181	3,867	3,836	2,318	2,177
250K - 1 Mil. Pop.	4,128	3,936	2,510	2,431	1,456	1,358
< 250K Pop.	2,289	2,245	1,357	1,405	862	819
Nonmetro	2,616	2,551	1,492	1,420	854	784
Urbanized	1,322	1,234	803	731	467	397
Less Urbanized	1,088	1,125	582	587	325	335
Completely Rural	206	192	107	102	62	52

130328

Table 1.61B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	56.9	57.8	35.2	36.3	21.4	21.3
GEOGRAPHIC DIVISION
Northeast	57.8	60.0	38.1	41.2	23.0	24.8
New England	62.8	64.7	43.7	45.6	27.8	28.4
Middle Atlantic	56.1	58.3	36.1	39.6	21.3	23.5
Midwest	56.8	57.8	34.6	35.1	20.6	20.1
East North Central	58.0	58.8	35.4	35.7	21.4	22.1
West North Central	54.0	55.6	32.8	33.8	18.9^a	15.6
South	55.5	55.2	32.5	33.1	19.4	18.7
South Atlantic	58.0	56.2	35.2	35.1	21.3	20.7
East South Central	54.3	53.7	31.0	30.8	18.7	17.3
West South Central	52.1	54.3	28.9	31.3	16.6	16.2
West	58.6	60.0	37.7	38.5	24.1	23.9
Mountain	60.6	60.6	35.8	37.0	21.6	22.3
Pacific	57.8	59.7	38.5	39.2	25.2	24.6
COUNTY TYPE
Large Metro	57.0^a	59.4	36.4^a	38.5	22.7	23.4
Small Metro	57.6	57.2	34.7	35.5	20.8	20.1
250K - 1 Mil. Pop.	58.3	57.1	35.4	35.3	20.6	19.7
< 250K Pop.	56.3	57.2	33.4	35.8	21.2	20.9
Nonmetro	55.1	52.6	31.4	29.3	18.0	16.2
Urbanized	59.9	55.5	36.4	32.9	21.2	17.9
Less Urbanized	52.0	51.5	27.8	26.9	15.5	15.4
Completely Rural	46.4	42.9	24.1	22.8	14.0	11.6

130328

Table 1.62A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	95,171^b	98,787	21,485^b	24,460	12,580^a	14,105
GEOGRAPHIC DIVISION
Northeast	17,900	18,376	4,077	4,531	2,467	2,601
New England	5,284	5,557	1,239	1,351	689	832
Middle Atlantic	12,616	12,818	2,838	3,180	1,778	1,769
Midwest	20,810	21,530	4,341^a	5,063	2,714	2,808
East North Central	14,605^a	15,531	3,270^a	3,905	2,117	2,178
West North Central	6,206	5,999	1,071	1,158	597	630
South	33,708	34,398	7,074	7,692	3,841	4,222
South Atlantic	18,525	19,332	3,820	4,108	1,949	2,405
East South Central	5,398	5,080	1,114	1,137	724	584
West South Central	9,786	9,986	2,139	2,447	1,168	1,233
West	22,752^a	24,483	5,993^b	7,174	3,557^b	4,474
Mountain	7,101	7,614	1,672	1,999	903	1,119
Pacific	15,652	16,870	4,321^a	5,175	2,654^a	3,355
COUNTY TYPE
Large Metro	51,824	53,111	12,198^b	14,041	7,079^a	8,009
Small Metro	29,751	30,948	6,591	7,222	3,825	4,357
250K - 1 Mil. Pop.	20,526	21,141	4,453	5,001	2,684	3,025
< 250K Pop.	9,225	9,807	2,138	2,221	1,140	1,332
Nonmetro	13,596	14,729	2,696	3,197	1,677	1,739
Urbanized	6,073	7,019	1,259	1,640	789	966
Less Urbanized	6,096	6,133	1,172	1,327	740	644
Completely Rural	1,426	1,576	265	231	148	129

130328

Table 1.62B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	48.0	49.3	10.8^b	12.2	6.3^a	7.0
GEOGRAPHIC DIVISION
Northeast	49.0	50.0	11.2	12.3	6.8	7.1
New England	55.0	57.4	12.9	13.9	7.2	8.6
Middle Atlantic	46.9	47.3	10.6	11.7	6.6	6.5
Midwest	48.5	49.9	10.1^a	11.7	6.3	6.5
East North Central	49.0^a	51.8	11.0^a	13.0	7.1	7.3
West North Central	47.4	45.5	8.2	8.8	4.6	4.8
South	46.0	46.3	9.6	10.4	5.2	5.7
South Atlantic	47.4	48.7	9.8	10.4	5.0	6.1
East South Central	45.7	42.7	9.4	9.6	6.1	4.9
West South Central	43.7	43.9	9.6	10.8	5.2	5.4
West	49.9	52.9	13.1^a	15.5	7.8^a	9.7
Mountain	51.3	54.1	12.1	14.2	6.5	8.0
Pacific	49.3	52.4	13.6^a	16.1	8.4^a	10.4
COUNTY TYPE
Large Metro	49.3	49.7	11.6^b	13.1	6.7	7.5
Small Metro	48.3^b	51.3	10.7	12.0	6.2	7.2
250K - 1 Mil. Pop.	48.8^a	51.7	10.6^a	12.2	6.4	7.4
< 250K Pop.	47.2	50.6	10.9	11.5	5.8	6.9
Nonmetro	43.0	44.0	8.5	9.6	5.3	5.2
Urbanized	47.1	48.6	9.8	11.3	6.1	6.7
Less Urbanized	39.8	40.6	7.7	8.8	4.8	4.3
Completely Rural	41.9	40.4	7.8	5.9	4.3	3.3

130328

Table 1.63A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	114,705^b	118,764	33,552^b	37,011	19,932^a	21,486
GEOGRAPHIC DIVISION
Northeast	21,440	22,068	6,409	7,065	3,877	4,129
New England	6,291	6,606	1,941	2,090	1,135	1,292
Middle Atlantic	15,149	15,462	4,468	4,976	2,742	2,837
Midwest	24,978	25,785	6,878^a	7,651	4,227	4,285
East North Central	17,543^a	18,516	5,062^a	5,719	3,201	3,299
West North Central	7,435	7,269	1,817	1,931	1,026	987
South	40,707	41,438	11,168	11,920	6,283	6,607
South Atlantic	22,263	22,998	6,089	6,397	3,323	3,755
East South Central	6,489	6,166	1,737	1,760	1,100	935
West South Central	11,955	12,274	3,342	3,764	1,861	1,917
West	27,579^b	29,473	9,096^b	10,375	5,544^a	6,466
Mountain	8,598	9,126	2,557^a	2,920	1,438	1,676
Pacific	18,981^a	20,347	6,540^a	7,455	4,106	4,790
COUNTY TYPE
Large Metro	62,324	64,355	18,906^b	21,335	11,258^a	12,429
Small Metro	36,168	37,129	10,458	11,058	6,143	6,534
250K - 1 Mil. Pop.	24,654	25,077	6,963	7,432	4,140	4,383
< 250K Pop.	11,514	12,052	3,495	3,626	2,003	2,150
Nonmetro	16,212	17,280	4,188	4,617	2,531	2,524
Urbanized	7,395	8,253	2,062	2,370	1,257	1,364
Less Urbanized	7,184	7,258	1,754	1,915	1,064	979
Completely Rural	1,633	1,768	372	333	210	181

130328

Table 1.63B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	49.3^a	50.5	14.4^b	15.7	8.6^a	9.1
GEOGRAPHIC DIVISION
Northeast	50.3	51.4	15.0	16.5	9.1	9.6
New England	56.1	58.4	17.3	18.5	10.1	11.4
Middle Atlantic	48.2	48.9	14.2	15.7	8.7	9.0
Midwest	49.7	51.1	13.7^a	15.1	8.4	8.5
East North Central	50.3^a	52.8	14.5^a	16.3	9.2	9.4
West North Central	48.4	47.0	11.8	12.5	6.7	6.4
South	47.4	47.6	13.0	13.7	7.3	7.6
South Atlantic	48.9	49.8	13.4	13.8	7.3	8.1
East South Central	46.9	44.3	12.6	12.6	8.0	6.7
West South Central	45.1	45.6	12.6	14.0	7.0	7.1
West	51.2^a	54.0	16.9^a	19.0	10.3^a	11.8
Mountain	52.7	55.1	15.7	17.6	8.8	10.1
Pacific	50.6	53.5	17.4	19.6	10.9	12.6
COUNTY TYPE
Large Metro	50.5	51.2	15.3^b	17.0	9.1	9.9
Small Metro	49.7^b	52.2	14.4	15.6	8.4	9.2
250K - 1 Mil. Pop.	50.2^a	52.5	14.2	15.6	8.4	9.2
< 250K Pop.	48.7	51.7	14.8	15.6	8.5	9.2
Nonmetro	44.6	45.1	11.5	12.0	7.0	6.6
Urbanized	49.0	49.5	13.7	14.2	8.3	8.2
Less Urbanized	41.3	42.0	10.1	11.1	6.1	5.7
Completely Rural	42.5	40.6	9.7	7.6	5.5	4.2

130328

Table 1.64A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	107,842^a	111,239	29,739^a	31,513	18,071	18,855
GEOGRAPHIC DIVISION
Northeast	20,362	20,986	5,864	6,366	3,576	3,718
New England	5,916^a	6,448	1,830	1,974	1,096	1,235
Middle Atlantic	14,446	14,538	4,034	4,392	2,480	2,483
Midwest	23,534	24,550	6,138	6,512	3,796	3,787
East North Central	16,611^a	17,642	4,504	4,810	2,877	2,869
West North Central	6,923	6,908	1,634	1,702	919	917
South	37,899	38,384	9,412	9,878	5,465	5,626
South Atlantic	20,787	21,431	5,195	5,547	2,961	3,380
East South Central	5,996	5,737	1,440	1,364	960^a	720
West South Central	11,116	11,216	2,777	2,967	1,544	1,527
West	26,046	27,319	8,326	8,757	5,234	5,725
Mountain	7,868	8,370	2,201	2,447	1,332	1,493
Pacific	18,178	18,949	6,125	6,311	3,901	4,232
COUNTY TYPE
Large Metro	58,821	60,058	16,927	17,850	10,313	10,625
Small Metro	33,907	34,992	9,098	9,755	5,531	5,870
250K - 1 Mil. Pop.	23,082	23,662	6,188	6,493	3,740	3,905
< 250K Pop.	10,825	11,330	2,910	3,263	1,790	1,965
Nonmetro	15,114	16,189	3,715	3,908	2,227	2,360
Urbanized	6,868	7,738	1,855	2,000	1,120	1,289
Less Urbanized	6,738	6,777	1,549	1,592	931	887
Completely Rural	1,508	1,674	310	316	177	184

130328

Table 1.64B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	41.9	42.8	11.5^a	12.1	7.0	7.3
GEOGRAPHIC DIVISION
Northeast	43.4	44.5	12.5	13.5	7.6	7.9
New England	48.0	51.9	14.8	15.9	8.9	9.9
Middle Atlantic	41.8	41.8	11.7	12.6	7.2	7.1
Midwest	42.3	43.9	11.0	11.6	6.8	6.8
East North Central	42.9^a	45.4	11.6	12.4	7.4	7.4
West North Central	40.7	40.4	9.6	10.0	5.4	5.4
South	39.8	39.8	9.9	10.2	5.7	5.8
South Atlantic	41.4	42.1	10.4	10.9	5.9	6.6
East South Central	39.2	37.3	9.4	8.9	6.3^a	4.7
West South Central	37.4	37.2	9.4	9.8	5.2	5.1
West	43.5	45.1	13.9	14.5	8.7	9.4
Mountain	43.3	45.4	12.1	13.3	7.3	8.1
Pacific	43.6	44.9	14.7	15.0	9.4	10.0
COUNTY TYPE
Large Metro	43.0	43.1	12.4	12.8	7.5	7.6
Small Metro	42.1^b	44.6	11.3^a	12.4	6.9	7.5
250K - 1 Mil. Pop.	42.4^a	44.7	11.4	12.3	6.9	7.4
< 250K Pop.	41.5	44.2	11.2	12.7	6.9	7.7
Nonmetro	37.6	38.3	9.2	9.3	5.5	5.6
Urbanized	40.9	41.9	11.0	10.8	6.7	7.0
Less Urbanized	35.1	35.7	8.1	8.4	4.9	4.7
Completely Rural	35.9	35.1	7.4	6.6	4.2	3.9

130328

Table 1.65A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	4,378	4,232	3,553	3,363	1,967^a	1,800
GEOGRAPHIC DIVISION
Northeast	784	716	657	601	362	333
New England	244	217	219	189	129	111
Middle Atlantic	540	499	438	413	233	222
Midwest	855	893	692	727	382	401
East North Central	601	635	483	517	279	285
West North Central	254	259	209	210	102	116
South	1,435	1,504	1,144	1,202	621	617
South Atlantic	732	826	596	668	312	358
East South Central	212	197	170	145	102^a	64
West South Central	490	481	379	389	207	194
West	1,304^b	1,118	1,060^b	832	602^b	449
Mountain	376	356	312	259	178	150
Pacific	928^b	762	748^b	573	424^b	299
COUNTY TYPE
Large Metro	2,329	2,385	1,896	1,897	1,044	982
Small Metro	1,444^b	1,241	1,168^b	988	682^b	540
250K - 1 Mil. Pop.	1,015^a	863	838^b	684	477^a	386
< 250K Pop.	428	378	330	304	205	154
Nonmetro	605	606	490	478	242	278
Urbanized	314	288	265	226	131	129
Less Urbanized	236	256	187	200	91	116
Completely Rural	55	62	37	52	20	33

130328

Table 1.65B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	17.5	17.0	14.2	13.5	7.9^a	7.2
GEOGRAPHIC DIVISION
Northeast	18.3	16.9	15.4	14.2	8.5	7.9
New England	21.9	19.7	19.6	17.1	11.6	10.0
Middle Atlantic	17.1	15.9	13.9	13.2	7.4	7.1
Midwest	15.7	16.5	12.7	13.4	7.0	7.4
East North Central	15.8	16.8	12.7	13.7	7.3	7.6
West North Central	15.5	15.8	12.7	12.8	6.2	7.1
South	15.5	16.2	12.4	12.9	6.7	6.6
South Atlantic	15.8	17.8	12.9	14.4	6.8	7.7
East South Central	14.4	13.3	11.5	9.8	6.9^a	4.3
West South Central	15.5	15.1	12.0	12.2	6.6	6.1
West	21.8^b	18.7	17.7^b	13.9	10.1^b	7.5
Mountain	20.4	19.2	17.0^a	13.9	9.7	8.1
Pacific	22.3^a	18.5	18.0^b	13.9	10.2^b	7.3
COUNTY TYPE
Large Metro	17.5	17.5	14.2	13.9	7.8	7.2
Small Metro	18.4^a	16.7	14.9^a	13.3	8.7^a	7.3
250K - 1 Mil. Pop.	18.9^a	16.9	15.6^a	13.4	8.9	7.5
< 250K Pop.	17.3	16.4	13.3	13.2	8.3	6.7
Nonmetro	15.8	15.4	12.8	12.2	6.3	7.1
Urbanized	18.6	15.9	15.7^a	12.5	7.8	7.1
Less Urbanized	13.3	15.1	10.6	11.8	5.1	6.8
Completely Rural	15.3	14.9	10.5	12.5	5.7	8.0

130328

Table 1.66A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	17,796	18,052	10,554	10,887	6,526	6,485
GEOGRAPHIC DIVISION
Northeast	3,267^a	3,447	2,112	2,300	1,296	1,355
New England	944	984	649	680	416	424
Middle Atlantic	2,323	2,462	1,463	1,619	880	931
Midwest	3,801	3,833	2,218	2,214	1,337	1,311
East North Central	2,679	2,707	1,579	1,561	955	994
West North Central	1,123	1,125	639	652	383	317
South	6,271	6,321	3,485	3,603	2,086	2,033
South Atlantic	3,394	3,324	2,011	1,994	1,213	1,178
East South Central	978	971	494	510	309	285
West South Central	1,898	2,027	981	1,099	564	570
West	4,457	4,451	2,738	2,771	1,807	1,786
Mountain	1,357	1,346	752	773	476	478
Pacific	3,100	3,106	1,986	1,999	1,330	1,308
COUNTY TYPE
Large Metro	9,643	10,139	5,967	6,347	3,757	3,898
Small Metro	5,818	5,621	3,333	3,336	2,028	1,930
250K - 1 Mil. Pop.	3,755	3,552	2,172	2,082	1,304	1,191
< 250K Pop.	2,063	2,068	1,161	1,254	725	739
Nonmetro	2,334	2,293	1,255	1,204	740	657
Urbanized	1,186	1,113	673	623	414	344
Less Urbanized	957	1,005	482	496	270	263
Completely Rural	191	174	100	86	56	50

130328

Table 1.66B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	51.9	52.2	30.8	31.5	19.0	18.7
GEOGRAPHIC DIVISION
Northeast	53.4	56.0	34.5	37.4	21.2	22.0
New England	58.8	60.8	40.4	42.0	25.9	26.2
Middle Atlantic	51.4	54.3	32.4	35.7	19.5	20.5
Midwest	51.8	52.1	30.2	30.1	18.2	17.8
East North Central	52.9	53.3	31.2	30.8	18.8	19.6
West North Central	49.3	49.2	28.1	28.5	16.8	13.9
South	49.7	49.5	27.6	28.2	16.5	15.9
South Atlantic	52.7	50.9	31.2	30.5	18.8	18.0
East South Central	48.7	48.0	24.6	25.2	15.4	14.1
West South Central	45.6	48.2	23.6	26.1	13.6	13.5
West	54.1	53.5	33.3	33.3	21.9	21.5
Mountain	54.9	54.0	30.5	31.0	19.3	19.2
Pacific	53.8	53.3	34.5	34.3	23.1	22.5
COUNTY TYPE
Large Metro	52.4	53.6	32.4	33.5	20.4	20.6
Small Metro	52.2	52.0	29.9	30.9	18.2	17.8
250K - 1 Mil. Pop.	53.0	51.6	30.7	30.2	18.4	17.3
< 250K Pop.	50.8	52.7	28.6^a	32.0	17.8	18.8
Nonmetro	49.2	47.3	26.4	24.8	15.6	13.5
Urbanized	53.7	50.1	30.5	28.0	18.7	15.5
Less Urbanized	45.7	46.1	23.0	22.7	12.9	12.1
Completely Rural	43.1	39.0	22.4	19.2	12.7	11.2

130328

Table 1.67A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	85,668^a	88,955	15,632^a	17,263	9,578	10,571
GEOGRAPHIC DIVISION
Northeast	16,311	16,823	3,094	3,465	1,918	2,030
New England	4,728^a	5,246	962	1,105	551	700
Middle Atlantic	11,583	11,577	2,132	2,360	1,367	1,330
Midwest	18,878	19,824	3,228	3,571	2,078	2,074
East North Central	13,332^a	14,300	2,442	2,731	1,643	1,590
West North Central	5,546	5,524	786	840	434	484
South	30,194	30,559	4,782	5,073	2,758	2,977
South Atlantic	16,661	17,281	2,588	2,886	1,435	1,843
East South Central	4,806	4,570	777	709	550	371
West South Central	8,727	8,708	1,417	1,479	773	763
West	20,285^a	21,750	4,527	5,154	2,825^a	3,490
Mountain	6,135	6,668	1,136	1,415	678	864
Pacific	14,150	15,082	3,391	3,739	2,147	2,626
COUNTY TYPE
Large Metro	46,848	47,534	9,064	9,606	5,512	5,746
Small Metro	26,645	28,131	4,597^a	5,431	2,821	3,400
250K - 1 Mil. Pop.	18,311	19,247	3,177	3,727	1,960	2,328
< 250K Pop.	8,334	8,884	1,419	1,705	861	1,072
Nonmetro	12,175	13,290	1,970	2,225	1,245	1,424
Urbanized	5,368^a	6,336	917	1,151	575	816
Less Urbanized	5,545	5,516	880	896	570	508
Completely Rural	1,262	1,438	173	178	100	101

130328

Table 1.67B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	43.2	44.4	7.9^a	8.6	4.8	5.3
GEOGRAPHIC DIVISION
Northeast	44.7	45.7	8.5	9.4	5.3	5.5
New England	49.2	54.2	10.0	11.4	5.7	7.2
Middle Atlantic	43.1	42.7	7.9	8.7	5.1	4.9
Midwest	44.0	45.9	7.5	8.3	4.8	4.8
East North Central	44.7^a	47.7	8.2	9.1	5.5	5.3
West North Central	42.4	41.9	6.0	6.4	3.3	3.7
South	41.2	41.1	6.5	6.8	3.8	4.0
South Atlantic	42.6	43.5	6.6	7.3	3.7	4.6
East South Central	40.7	38.4	6.6	6.0	4.7	3.1
West South Central	39.0	38.3	6.3	6.5	3.5	3.4
West	44.5	47.0	9.9	11.1	6.2	7.5
Mountain	44.3	47.4	8.2	10.1	4.9	6.1
Pacific	44.6	46.8	10.7	11.6	6.8	8.1
COUNTY TYPE
Large Metro	44.6	44.5	8.6	9.0	5.2	5.4
Small Metro	43.2^b	46.7	7.5^b	9.0	4.6^a	5.6
250K - 1 Mil. Pop.	43.5^b	47.1	7.6^a	9.1	4.7	5.7
< 250K Pop.	42.6	45.8	7.3	8.8	4.4	5.5
Nonmetro	38.5	39.7	6.2	6.6	3.9	4.3
Urbanized	41.6	43.9	7.1	8.0	4.5	5.6
Less Urbanized	36.2	36.5	5.7	5.9	3.7	3.4
Completely Rural	37.1	36.8	5.1	4.6	2.9	2.6

130328

Table 1.68A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	103,464^a	107,007	26,186^b	28,150	16,103	17,055
GEOGRAPHIC DIVISION
Northeast	19,578	20,270	5,207	5,764	3,214	3,385
New England	5,672^a	6,231	1,611	1,785	967	1,124
Middle Atlantic	13,906	14,039	3,596	3,979	2,247	2,261
Midwest	22,679	23,656	5,446	5,785	3,415	3,385
East North Central	16,010^a	17,007	4,021	4,292	2,598	2,584
West North Central	6,669	6,649	1,425	1,493	817	801
South	36,465	36,880	8,268	8,676	4,844	5,009
South Atlantic	20,055	20,604	4,599	4,880	2,649	3,021
East South Central	5,784	5,541	1,271	1,219	858	656
West South Central	10,625	10,735	2,398	2,577	1,337	1,332
West	24,742^a	26,201	7,265	7,925	4,631	5,276
Mountain	7,492	8,013	1,888	2,188	1,154	1,342
Pacific	17,250	18,188	5,377	5,737	3,477	3,933
COUNTY TYPE
Large Metro	56,492	57,673	15,031	15,953	9,269	9,644
Small Metro	32,463	33,751	7,930^a	8,767	4,849	5,330
250K - 1 Mil. Pop.	22,066	22,799	5,349	5,809	3,264	3,519
< 250K Pop.	10,397	10,952	2,580	2,959	1,585	1,811
Nonmetro	14,509	15,583	3,225	3,430	1,985	2,082
Urbanized	6,554	7,450	1,590	1,774	989	1,160
Less Urbanized	6,502	6,521	1,363	1,392	840	771
Completely Rural	1,453	1,612	273	264	157	151

130328

Table 1.68B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	44.5	45.5	11.3^a	12.0	6.9	7.3
GEOGRAPHIC DIVISION
Northeast	45.9	47.2	12.2	13.4	7.5	7.9
New England	50.6^a	55.1	14.4	15.8	8.6	9.9
Middle Atlantic	44.3	44.4	11.4	12.6	7.2	7.1
Midwest	45.1	46.8	10.8	11.5	6.8	6.7
East North Central	45.9^a	48.5	11.5	12.3	7.4	7.4
West North Central	43.4	43.0	9.3	9.6	5.3	5.2
South	42.4	42.4	9.6	10.0	5.6	5.8
South Atlantic	44.0	44.6	10.1	10.6	5.8	6.5
East South Central	41.8	39.8	9.2	8.8	6.2	4.7
West South Central	40.0	39.9	9.0	9.6	5.0	4.9
West	46.0	48.0	13.5	14.5	8.6	9.7
Mountain	45.9	48.4	11.6	13.2	7.1	8.1
Pacific	46.0	47.8	14.3	15.1	9.3	10.3
COUNTY TYPE
Large Metro	45.7	45.9	12.2	12.7	7.5	7.7
Small Metro	44.6^b	47.5	10.9^b	12.3	6.7	7.5
250K - 1 Mil. Pop.	44.9^a	47.7	10.9	12.2	6.6	7.4
< 250K Pop.	44.0	47.0	10.9^a	12.7	6.7	7.8
Nonmetro	39.9	40.7	8.9	9.0	5.5	5.4
Urbanized	43.4	44.7	10.5	10.6	6.5	7.0
Less Urbanized	37.4	37.7	7.8	8.0	4.8	4.5
Completely Rural	37.8	37.0	7.1	6.1	4.1	3.5

130328

Table 1.69A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	36,921	37,688	3,857^b	4,671	1,369	1,650
GEOGRAPHIC DIVISION
Northeast	6,989	7,025	921	1,042	360	387
New England	2,101	2,240	243	239	86	114
Middle Atlantic	4,888	4,785	678	803	273	273
Midwest	6,981	7,319	729	720	267	287
East North Central	5,076	5,377	567	560	218	224
West North Central	1,905	1,942	162	160	49	62
South	12,174	12,161	1,186^a	1,612	399	576
South Atlantic	6,627	6,757	631^a	970	182	356
East South Central	2,006	1,617	158	200	64	90
West South Central	3,541	3,786	397	443	154	131
West	10,777	11,183	1,020	1,297	344	400
Mountain	3,351	3,426	287	419	103	131
Pacific	7,426	7,757	732	878	241	269
COUNTY TYPE
Large Metro	20,358	21,028	2,379^a	2,918	864	1,098
Small Metro	11,795	11,904	1,134	1,381	399	431
250K - 1 Mil. Pop.	8,316	8,116	765	989	253	292
< 250K Pop.	3,479	3,789	369	392	146	139
Nonmetro	4,768	4,756	343	371	106	121
Urbanized	2,098	2,397	197	154	66	59
Less Urbanized	2,135	1,992	118	167	29	34
Completely Rural	535	367	29	51	10	28

130328

Table 1.69B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	14.3	14.5	1.5^b	1.8	0.5	0.6
GEOGRAPHIC DIVISION
Northeast	14.9	14.9	2.0	2.2	0.8	0.8
New England	17.0	18.0	2.0	1.9	0.7	0.9
Middle Atlantic	14.1	13.8	2.0	2.3	0.8	0.8
Midwest	12.5	13.1	1.3	1.3	0.5	0.5
East North Central	13.1	13.9	1.5	1.4	0.6	0.6
West North Central	11.2	11.4	1.0	0.9	0.3	0.4
South	12.8	12.6	1.2^a	1.7	0.4	0.6
South Atlantic	13.2	13.3	1.3^a	1.9	0.4	0.7
East South Central	13.1	10.5	1.0	1.3	0.4	0.6
West South Central	11.9	12.6	1.3	1.5	0.5	0.4
West	18.0	18.5	1.7	2.1	0.6	0.7
Mountain	18.5	18.6	1.6	2.3	0.6	0.7
Pacific	17.8	18.4	1.8	2.1	0.6	0.6
COUNTY TYPE
Large Metro	14.9	15.1	1.7^a	2.1	0.6	0.8
Small Metro	14.6	15.2	1.4	1.8	0.5	0.5
250K - 1 Mil. Pop.	15.3	15.3	1.4^a	1.9	0.5	0.6
< 250K Pop.	13.3	14.8	1.4	1.5	0.6	0.5
Nonmetro	11.9	11.3	0.9	0.9	0.3	0.3
Urbanized	12.5	13.0	1.2	0.8	0.4	0.3
Less Urbanized	11.1	10.5	0.6	0.9	0.2	0.2
Completely Rural	12.7^a	7.7	0.7	1.1	0.2	0.6

130328

Table 1.70A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	337^a	265	229	180	67^b	30
GEOGRAPHIC DIVISION
Northeast	52	35	38	24	10	6
New England	23^a	9	20	6	7	1
Middle Atlantic	29	26	18	17	3	5
Midwest	61	40	42^a	20	18^a	5
East North Central	47	34	34^a	14	15^a	4
West North Central	15	6	8	6	3	1
South	112	104	71	79	17	14
South Atlantic	52	27	30	23	8	2
East South Central	13	16	10	13	1	4
West South Central	48	61	31	43	7	8
West	111	86	77	57	23^a	5
Mountain	25	34	19	21	6	0
Pacific	86	52	59	36	17	5
COUNTY TYPE
Large Metro	168	146	121	102	41^a	15
Small Metro	125^a	81	79	58	18	10
250K - 1 Mil. Pop.	94	60	60	43	16	7
< 250K Pop.	31	21	20	15	2	3
Nonmetro	44	39	29	20	9	5
Urbanized	23	16	14	7	2	3
Less Urbanized	16	20	13	11	6	2
Completely Rural	4	*	2	*	*	*

130328

Table 1.70B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	1.3^a	1.1	0.9	0.7	0.3^b	0.1
GEOGRAPHIC DIVISION
Northeast	1.2	0.8	0.9	0.6	0.2	0.1
New England	2.1^a	0.8	1.8	0.6	0.6	0.1
Middle Atlantic	0.9	0.8	0.6	0.6	0.1	0.2
Midwest	1.1	0.7	0.8^a	0.4	0.3^a	0.1
East North Central	1.2	0.9	0.9^a	0.4	0.4^a	0.1
West North Central	0.9	0.4	0.5	0.3	0.2	0.1
South	1.2	1.1	0.8	0.9	0.2	0.2
South Atlantic	1.1	0.6	0.7	0.5	0.2	0.0
East South Central	0.9	1.1	0.7	0.9	0.1	0.3
West South Central	1.5	1.9	1.0	1.4	0.2	0.2
West	1.9	1.4	1.3	1.0	0.4^a	0.1
Mountain	1.4	1.8	1.0	1.1	0.3	0.0
Pacific	2.1	1.3	1.4	0.9	0.4	0.1
COUNTY TYPE
Large Metro	1.3	1.1	0.9	0.7	0.3^b	0.1
Small Metro	1.6	1.1	1.0	0.8	0.2	0.1
250K - 1 Mil. Pop.	1.7	1.2	1.1	0.8	0.3	0.1
< 250K Pop.	1.3	0.9	0.8	0.6	0.1	0.1
Nonmetro	1.1	1.0	0.8	0.5	0.2	0.1
Urbanized	1.4	0.9	0.9	0.4	0.1	0.2
Less Urbanized	0.9	1.2	0.7	0.6	0.3	0.1
Completely Rural	1.2	*	0.5	*	*	*

130328

Table 1.71A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	4,253	4,267	1,563	1,600	464	398
GEOGRAPHIC DIVISION
Northeast	728	761	314	339	93	85
New England	249	217	104	92	23	30
Middle Atlantic	479	544	209	246	69	55
Midwest	823	786	284^a	217	85	56
East North Central	539	543	203	157	54	45
West North Central	284	242	81	60	30	10
South	1,389	1,495	471	526	142	143
South Atlantic	656	765	254	310	75	89
East South Central	238	195	53	59	18	21
West South Central	495	535	164	158	49	34
West	1,313	1,226	494	518	145	114
Mountain	434	433	160	155	37	39
Pacific	880	793	334	363	108	74
COUNTY TYPE
Large Metro	2,236	2,429	891	1,007	268	254
Small Metro	1,444	1,298	499	452	154	111
250K - 1 Mil. Pop.	953	814	344	291	100	75
< 250K Pop.	491	484	155	162	54	36
Nonmetro	573	541	173	141	42	32
Urbanized	312	273	100	72	26	17
Less Urbanized	215	231	55	59	13	10
Completely Rural	45	37	18	11	3	5

130328

Table 1.71B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	12.4	12.3	4.6	4.6	1.4	1.1
GEOGRAPHIC DIVISION
Northeast	11.9	12.4	5.1	5.5	1.5	1.4
New England	15.5	13.4	6.5	5.7	1.4	1.9
Middle Atlantic	10.6	12.0	4.6	5.4	1.5	1.2
Midwest	11.2	10.7	3.9^a	2.9	1.2	0.8
East North Central	10.6	10.7	4.0	3.1	1.1	0.9
West North Central	12.5	10.6	3.6	2.6	1.3	0.5
South	11.0	11.7	3.7	4.1	1.1	1.1
South Atlantic	10.2	11.7	3.9	4.8	1.2	1.4
East South Central	11.8	9.6	2.7	2.9	0.9	1.0
West South Central	11.9	12.7	3.9	3.7	1.2	0.8
West	16.0	14.7	6.0	6.2	1.8	1.4
Mountain	17.6	17.4	6.5	6.2	1.5	1.6
Pacific	15.3	13.6	5.8	6.2	1.9	1.3
COUNTY TYPE
Large Metro	12.1	12.8	4.8	5.3	1.5	1.3
Small Metro	13.0	12.0	4.5	4.2	1.4	1.0
250K - 1 Mil. Pop.	13.5	11.8	4.9	4.2	1.4	1.1
< 250K Pop.	12.1	12.3	3.8	4.1	1.3	0.9
Nonmetro	12.1	11.1	3.7	2.9	0.9	0.7
Urbanized	14.1	12.3	4.5	3.2	1.2	0.8
Less Urbanized	10.3	10.6	2.6	2.7	0.6	0.5
Completely Rural	10.2	8.2	3.9	2.5	0.6	1.1

130328

Table 1.72A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	32,332	33,156	2,065^b	2,890	838^a	1,222
GEOGRAPHIC DIVISION
Northeast	6,209	6,229	569	680	257	296
New England	1,829	2,014	119	141	56	83
Middle Atlantic	4,380	4,214	451	539	201	213
Midwest	6,097	6,494	403	484	165	226
East North Central	4,490	4,799	330	389	149	176
West North Central	1,607	1,694	73	94	16	50
South	10,673	10,562	644^a	1,006	241	419
South Atlantic	5,919	5,965	346^a	637	99	265
East South Central	1,756	1,406	95	128	44	65
West South Central	2,999	3,191	203	242	98	89
West	9,353	9,872	448^a	721	176	282
Mountain	2,893	2,959	108^a	242	60	91
Pacific	6,460	6,913	340	479	116	190
COUNTY TYPE
Large Metro	17,954	18,454	1,367^a	1,810	556	829
Small Metro	10,226	10,526	556^a	871	227	310
250K - 1 Mil. Pop.	7,270	7,242	361^b	656	137	210
< 250K Pop.	2,956	3,284	195	215	90	100
Nonmetro	4,152	4,177	141	210	55	83
Urbanized	1,763	2,108	82	76	39	40
Less Urbanized	1,903	1,741	50	97	10	21
Completely Rural	485	328	9	37	6	23

130328

Table 1.72B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	16.3	16.5	1.0^b	1.4	0.4^a	0.6
GEOGRAPHIC DIVISION
Northeast	17.0	16.9	1.6	1.8	0.7	0.8
New England	19.0	20.8	1.2	1.5	0.6	0.9
Middle Atlantic	16.3	15.6	1.7	2.0	0.7	0.8
Midwest	14.2	15.0	0.9	1.1	0.4	0.5
East North Central	15.1	16.0	1.1	1.3	0.5	0.6
West North Central	12.3	12.9	0.6	0.7	0.1	0.4
South	14.6	14.2	0.9^a	1.4	0.3	0.6
South Atlantic	15.1	15.0	0.9^a	1.6	0.3	0.7
East South Central	14.9	11.8	0.8	1.1	0.4	0.5
West South Central	13.4	14.0	0.9	1.1	0.4	0.4
West	20.5	21.3	1.0^a	1.6	0.4	0.6
Mountain	20.9	21.0	0.8^a	1.7	0.4	0.6
Pacific	20.3	21.5	1.1	1.5	0.4	0.6
COUNTY TYPE
Large Metro	17.1	17.3	1.3	1.7	0.5	0.8
Small Metro	16.6	17.5	0.9^a	1.4	0.4	0.5
250K - 1 Mil. Pop.	17.3	17.7	0.9^b	1.6	0.3	0.5
< 250K Pop.	15.1	16.9	1.0	1.1	0.5	0.5
Nonmetro	13.1	12.5	0.4	0.6	0.2	0.2
Urbanized	13.7	14.6	0.6	0.5	0.3	0.3
Less Urbanized	12.4	11.5	0.3	0.6	0.1	0.1
Completely Rural	14.3^a	8.4	0.3	0.9	0.2	0.6

130328

Table 1.73A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	36,584	37,423	3,628^b	4,491	1,302	1,620
GEOGRAPHIC DIVISION
Northeast	6,937	6,990	883	1,018	349	381
New England	2,077	2,231	223	233	79	113
Middle Atlantic	4,859	4,759	660	786	270	268
Midwest	6,920	7,279	687	700	249	282
East North Central	5,030	5,343	533	546	203	221
West North Central	1,891	1,936	154	154	46	61
South	12,062	12,057	1,116^a	1,532	383	562
South Atlantic	6,575	6,730	601^a	947	174	353
East South Central	1,993	1,601	149	186	62	86
West South Central	3,494	3,725	367	399	147	123
West	10,666	11,097	942^a	1,240	321	395
Mountain	3,326	3,392	268	398	97	131
Pacific	7,340	7,705	674	842	224	265
COUNTY TYPE
Large Metro	20,190	20,882	2,258^a	2,816	824	1,083
Small Metro	11,670	11,824	1,055	1,323	381	421
250K - 1 Mil. Pop.	8,222	8,056	706^a	947	237	286
< 250K Pop.	3,448	3,768	349	377	145	135
Nonmetro	4,725	4,717	315	351	97	116
Urbanized	2,075	2,380	183	147	65	57
Less Urbanized	2,119	1,973	105	156	23	31
Completely Rural	531	364	27	48	9	28

130328

Table 1.73B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	15.7	15.9	1.6^b	1.9	0.6	0.7
GEOGRAPHIC DIVISION
Northeast	16.3	16.3	2.1	2.4	0.8	0.9
New England	18.5	19.7	2.0	2.1	0.7	1.0
Middle Atlantic	15.5	15.0	2.1	2.5	0.9	0.8
Midwest	13.8	14.4	1.4	1.4	0.5	0.6
East North Central	14.4	15.2	1.5	1.6	0.6	0.6
West North Central	12.3	12.5	1.0	1.0	0.3	0.4
South	14.0	13.8	1.3^a	1.8	0.4	0.6
South Atlantic	14.4	14.6	1.3^a	2.0	0.4	0.8
East South Central	14.4	11.5	1.1	1.3	0.5	0.6
West South Central	13.2	13.8	1.4	1.5	0.6	0.5
West	19.8	20.3	1.7	2.3	0.6	0.7
Mountain	20.4	20.5	1.6	2.4	0.6	0.8
Pacific	19.6	20.3	1.8	2.2	0.6	0.7
COUNTY TYPE
Large Metro	16.3	16.6	1.8^a	2.2	0.7	0.9
Small Metro	16.0	16.6	1.4^a	1.9	0.5	0.6
250K - 1 Mil. Pop.	16.7	16.9	1.4^a	2.0	0.5	0.6
< 250K Pop.	14.6	16.2	1.5	1.6	0.6	0.6
Nonmetro	13.0	12.3	0.9	0.9	0.3	0.3
Urbanized	13.7	14.3	1.2	0.9	0.4	0.3
Less Urbanized	12.2	11.4	0.6	0.9	0.1	0.2
Completely Rural	13.8^a	8.4	0.7	1.1	0.2	0.6

130328

Table 1.74A – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	8,214	9,015	625^a	921	228^a	443
GEOGRAPHIC DIVISION
Northeast	1,388	1,331	138	177	63	86
New England	353	314	46	27	21	12
Middle Atlantic	1,035	1,017	93	150	42	74
Midwest	1,698	1,883	164	183	76	84
East North Central	1,247	1,334	137	163	66	77
West North Central	451	549	27	20	9	7
South	2,870	3,410	245^a	477	76	241
South Atlantic	1,578	1,875	136^a	319	43	194
East South Central	473	544	55	47	9	37
West South Central	819	991	53	111	23	11
West	2,258	2,391	78	84	14	32
Mountain	692	839	22	54	7	26
Pacific	1,566	1,552	57	30	7	6
COUNTY TYPE
Large Metro	4,231	4,605	302	504	99^a	276
Small Metro	2,702	3,132	245	294	100	121
250K - 1 Mil. Pop.	1,863	2,052	136	185	67	102
< 250K Pop.	840	1,079	109	110	33	19
Nonmetro	1,280	1,279	79	124	30	46
Urbanized	535	546	45	43	19	27
Less Urbanized	654	602	26	54	3	9
Completely Rural	91	131	7	27	7	10

130328

Table 1.74B – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	3.2	3.5	0.2^a	0.4	0.1^a	0.2
GEOGRAPHIC DIVISION
Northeast	3.0	2.8	0.3	0.4	0.1	0.2
New England	2.9	2.5	0.4	0.2	0.2	0.1
Middle Atlantic	3.0	2.9	0.3	0.4	0.1	0.2
Midwest	3.0	3.4	0.3	0.3	0.1	0.2
East North Central	3.2	3.4	0.4	0.4	0.2	0.2
West North Central	2.7	3.2	0.2	0.1	0.1	0.0
South	3.0	3.5	0.3^a	0.5	0.1	0.3
South Atlantic	3.1	3.7	0.3	0.6	0.1	0.4
East South Central	3.1	3.5	0.4	0.3	0.1	0.2
West South Central	2.8	3.3	0.2	0.4	0.1	0.0
West	3.8	3.9	0.1	0.1	0.0	0.1
Mountain	3.8	4.6	0.1	0.3	0.0	0.1
Pacific	3.8	3.7	0.1	0.1	0.0	0.0
COUNTY TYPE
Large Metro	3.1	3.3	0.2	0.4	0.1^a	0.2
Small Metro	3.4^a	4.0	0.3	0.4	0.1	0.2
250K - 1 Mil. Pop.	3.4	3.9	0.2	0.3	0.1	0.2
< 250K Pop.	3.2	4.2	0.4	0.4	0.1	0.1
Nonmetro	3.2	3.0	0.2	0.3	0.1	0.1
Urbanized	3.2	3.0	0.3	0.2	0.1	0.1
Less Urbanized	3.4	3.2	0.1	0.3	0.0	0.0
Completely Rural	2.2	2.7	0.2	0.6	0.2	0.2

130328

Table 1.75A – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	36,362	37,908	4,069	4,306	972	1,134
GEOGRAPHIC DIVISION
Northeast	6,610	6,917	722	752	173	187
New England	2,072	2,421	236	208	74	58
Middle Atlantic	4,538	4,496	486	543	99	129
Midwest	7,381	7,707	751	708	162	217
East North Central	5,224	5,523	530	569	104	178
West North Central	2,157	2,185	221^a	138	58	39
South	11,592	11,690	1,184	1,431	292	418
South Atlantic	6,145	6,668	665^a	904	124^b	299
East South Central	1,754	1,472	128	158	55	35
West South Central	3,693	3,551	390	369	113	84
West	10,779	11,593	1,412	1,416	346	311
Mountain	3,346	3,595	374	445	113	100
Pacific	7,433	7,998	1,038	971	233	211
COUNTY TYPE
Large Metro	19,624	20,675	2,356	2,558	575	640
Small Metro	11,815	12,237	1,307	1,367	298	411
250K - 1 Mil. Pop.	8,269	8,508	916	869	207	263
< 250K Pop.	3,546	3,729	390	498	91	148
Nonmetro	4,923	4,996	406	382	99	82
Urbanized	2,250	2,587	221	192	51	35
Less Urbanized	2,189	2,001	164	149	42	35
Completely Rural	484	409	21	41	6	13

130328

Table 1.75B – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	14.1	14.6	1.6	1.7	0.4	0.4
GEOGRAPHIC DIVISION
Northeast	14.1	14.7	1.5	1.6	0.4	0.4
New England	16.8	19.5	1.9	1.7	0.6	0.5
Middle Atlantic	13.1	12.9	1.4	1.6	0.3	0.4
Midwest	13.3	13.8	1.3	1.3	0.3	0.4
East North Central	13.5	14.2	1.4	1.5	0.3	0.5
West North Central	12.7	12.8	1.3^a	0.8	0.3	0.2
South	12.2	12.1	1.2	1.5	0.3	0.4
South Atlantic	12.2	13.1	1.3^a	1.8	0.2^b	0.6
East South Central	11.5	9.6	0.8	1.0	0.4	0.2
West South Central	12.4	11.8	1.3	1.2	0.4	0.3
West	18.0	19.1	2.4	2.3	0.6	0.5
Mountain	18.4	19.5	2.1	2.4	0.6	0.5
Pacific	17.8	19.0	2.5	2.3	0.6	0.5
COUNTY TYPE
Large Metro	14.3	14.8	1.7	1.8	0.4	0.5
Small Metro	14.7	15.6	1.6	1.7	0.4	0.5
250K - 1 Mil. Pop.	15.2	16.1	1.7	1.6	0.4	0.5
< 250K Pop.	13.6	14.6	1.5	1.9	0.3	0.6
Nonmetro	12.3	11.8	1.0	0.9	0.2	0.2
Urbanized	13.4	14.0	1.3	1.0	0.3	0.2
Less Urbanized	11.4	10.5	0.9	0.8	0.2	0.2
Completely Rural	11.5	8.6	0.5	0.9	0.1	0.3

130328

Table 1.76A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	20,523	21,095	1,861	1,693	624	493
GEOGRAPHIC DIVISION
Northeast	4,323	3,892	351	266	110^b	43
New England	1,174	1,200	104	73	33	11
Middle Atlantic	3,149	2,692	247	193	77^a	32
Midwest	4,181	4,373	351	297	116	100
East North Central	3,034	3,182	208	221	52	71
West North Central	1,147	1,191	143^a	76	64	29
South	6,411	6,961	533	602	208	190
South Atlantic	3,356^a	4,039	294	350	121	100
East South Central	1,039	1,018	71	77	27	23
West South Central	2,016	1,905	168	175	60	68
West	5,608	5,867	626	528	190	160
Mountain	1,710	2,043	212	133	54	33
Pacific	3,898	3,824	415	395	135	126
COUNTY TYPE
Large Metro	11,277	11,149	974	987	290	328
Small Metro	6,706	7,091	683^b	447	270^b	107
250K - 1 Mil. Pop.	4,805	4,719	495^a	313	212^b	67
< 250K Pop.	1,901^a	2,371	188	134	58	40
Nonmetro	2,541	2,855	203	259	64	58
Urbanized	1,190^a	1,520	100	157	39	21
Less Urbanized	1,145	1,115	89	74	23	25
Completely Rural	206	220	15	28	2	12

130328

Table 1.76B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	8.0	8.1	0.7	0.7	0.2	0.2
GEOGRAPHIC DIVISION
Northeast	9.2	8.3	0.7	0.6	0.2^b	0.1
New England	9.5	9.7	0.8	0.6	0.3	0.1
Middle Atlantic	9.1	7.7	0.7	0.6	0.2^a	0.1
Midwest	7.5	7.8	0.6	0.5	0.2	0.2
East North Central	7.8	8.2	0.5	0.6	0.1	0.2
West North Central	6.7	7.0	0.8^a	0.4	0.4	0.2
South	6.7	7.2	0.6	0.6	0.2	0.2
South Atlantic	6.7	7.9	0.6	0.7	0.2	0.2
East South Central	6.8	6.6	0.5	0.5	0.2	0.1
West South Central	6.8	6.3	0.6	0.6	0.2	0.2
West	9.4	9.7	1.0	0.9	0.3	0.3
Mountain	9.4	11.1	1.2	0.7	0.3	0.2
Pacific	9.4	9.1	1.0	0.9	0.3	0.3
COUNTY TYPE
Large Metro	8.2	8.0	0.7	0.7	0.2	0.2
Small Metro	8.3	9.0	0.8^a	0.6	0.3^b	0.1
250K - 1 Mil. Pop.	8.8	8.9	0.9^a	0.6	0.4^b	0.1
< 250K Pop.	7.3^a	9.3	0.7	0.5	0.2	0.2
Nonmetro	6.3	6.8	0.5	0.6	0.2	0.1
Urbanized	7.1	8.2	0.6	0.8	0.2	0.1
Less Urbanized	6.0	5.9	0.5	0.4	0.1	0.1
Completely Rural	4.9	4.6	0.3	0.6	0.0	0.3

130328

Table 1.77A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	1,877^b	1,613	820^b	647	223	188
GEOGRAPHIC DIVISION
Northeast	303	261	151^b	87	38^a	15
New England	73	58	38^a	22	8	3
Middle Atlantic	230	203	113^a	65	29^a	11
Midwest	406^a	347	162	139	42	42
East North Central	267	246	100	103	26	29
West North Central	139^a	101	63^a	35	16	13
South	632	596	251	253	77	83
South Atlantic	296	301	112	129	33	31
East South Central	102	101	45	39	19	16
West South Central	234	194	94	85	25	36
West	536^b	409	256^b	169	66	48
Mountain	148	126	71	46	11	15
Pacific	388^a	283	184^a	123	55	33
COUNTY TYPE
Large Metro	1,000^a	865	442	355	98	106
Small Metro	568^a	483	253^a	187	85^b	48
250K - 1 Mil. Pop.	398^a	318	196^b	127	68^b	33
< 250K Pop.	170	164	57	60	17	16
Nonmetro	310	265	125	105	39	34
Urbanized	120	119	57	44	18	11
Less Urbanized	161	120	59	48	19	17
Completely Rural	28	27	8	13	2	6

130328

Table 1.77B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	7.5^b	6.5	3.3^b	2.6	0.9	0.8
GEOGRAPHIC DIVISION
Northeast	7.1	6.1	3.5^b	2.1	0.9^a	0.3
New England	6.6	5.2	3.4^a	2.0	0.7	0.3
Middle Atlantic	7.3	6.5	3.6^a	2.1	0.9^a	0.4
Midwest	7.5	6.4	3.0	2.6	0.8	0.8
East North Central	7.0	6.5	2.6	2.7	0.7	0.8
West North Central	8.5^a	6.2	3.8^a	2.2	1.0	0.8
South	6.8	6.4	2.7	2.7	0.8	0.9
South Atlantic	6.4	6.5	2.4	2.8	0.7	0.7
East South Central	6.9	6.8	3.1	2.7	1.3	1.1
West South Central	7.4	6.1	3.0	2.7	0.8	1.1
West	8.9^b	6.8	4.3^a	2.8	1.1	0.8
Mountain	8.0	6.8	3.9	2.5	0.6	0.8
Pacific	9.3^a	6.9	4.4^a	3.0	1.3	0.8
COUNTY TYPE
Large Metro	7.5^a	6.4	3.3^a	2.6	0.7	0.8
Small Metro	7.2	6.5	3.2^a	2.5	1.1^a	0.7
250K - 1 Mil. Pop.	7.4^a	6.2	3.6^b	2.5	1.3^b	0.6
< 250K Pop.	6.9	7.1	2.3	2.6	0.7	0.7
Nonmetro	8.1^a	6.8	3.3	2.7	1.0	0.9
Urbanized	7.1	6.5	3.4	2.4	1.1	0.6
Less Urbanized	9.1	7.1	3.3	2.9	1.1	1.0
Completely Rural	8.0	6.4	2.4	3.1	0.4	1.4

130328

Table 1.78A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	51,243^b	54,389	14,657^b	16,666	6,119^a	6,831
GEOGRAPHIC DIVISION
Northeast	8,532	9,116	2,466	2,738	1,048	1,055
New England	2,350	2,599	691	686	278	277
Middle Atlantic	6,182	6,517	1,775	2,052	770	778
Midwest	10,685	11,045	3,144	3,372	1,393	1,302
East North Central	7,529	8,059	2,272	2,484	1,039	1,039
West North Central	3,156	2,986	871	887	354	263
South	18,419	19,039	5,334^a	6,075	2,145^a	2,661
South Atlantic	9,515	9,991	2,652	2,911	975^a	1,249
East South Central	3,095	2,954	927	1,058	422	492
West South Central	5,810	6,094	1,754^a	2,106	749	919
West	13,606^b	15,189	3,713^b	4,481	1,534	1,812
Mountain	4,405	4,630	1,239	1,354	469	540
Pacific	9,202^b	10,559	2,473^a	3,127	1,065	1,273
COUNTY TYPE
Large Metro	27,040^b	30,081	7,672^b	9,421	3,036^b	3,871
Small Metro	16,833	16,870	4,844	4,990	2,122	2,121
250K - 1 Mil. Pop.	11,692	11,547	3,207	3,377	1,398	1,493
< 250K Pop.	5,142	5,324	1,637	1,612	724	628
Nonmetro	7,369	7,438	2,141	2,256	961	839
Urbanized	3,398	3,645	1,101	1,062	485	394
Less Urbanized	3,196	3,084	873	1,010	405	378
Completely Rural	775	709	168	184	72	66

130328

Table 1.78B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	19.9^a	20.9	5.7^b	6.4	2.4	2.6
GEOGRAPHIC DIVISION
Northeast	18.2	19.3	5.3	5.8	2.2	2.2
New England	19.1	20.9	5.6	5.5	2.3	2.2
Middle Atlantic	17.9	18.7	5.1	5.9	2.2	2.2
Midwest	19.2	19.8	5.6	6.0	2.5	2.3
East North Central	19.5	20.8	5.9	6.4	2.7	2.7
West North Central	18.6	17.5	5.1	5.2	2.1	1.5
South	19.4	19.8	5.6^a	6.3	2.3^a	2.8
South Atlantic	19.0	19.6	5.3	5.7	1.9	2.5
East South Central	20.2	19.2	6.1	6.9	2.8	3.2
West South Central	19.6	20.2	5.9	7.0	2.5	3.1
West	22.7^a	25.1	6.2^a	7.4	2.6	3.0
Mountain	24.3	25.1	6.8	7.3	2.6	2.9
Pacific	22.1^a	25.0	5.9^a	7.4	2.6	3.0
COUNTY TYPE
Large Metro	19.8^b	21.6	5.6^b	6.8	2.2^b	2.8
Small Metro	20.9	21.5	6.0	6.4	2.6	2.7
250K - 1 Mil. Pop.	21.5	21.8	5.9	6.4	2.6	2.8
< 250K Pop.	19.7	20.8	6.3	6.3	2.8	2.5
Nonmetro	18.3	17.6	5.3	5.3	2.4	2.0
Urbanized	20.2	19.7	6.6	5.7	2.9	2.1
Less Urbanized	16.7	16.2	4.6	5.3	2.1	2.0
Completely Rural	18.5	14.9	4.0	3.9	1.7	1.4

130328

Table 1.79A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	2,522	2,482	1,749	1,642	688	693
GEOGRAPHIC DIVISION
Northeast	375	324	264	215	99	84
New England	89	74	60	55	21	23
Middle Atlantic	286	250	204^a	160	78	61
Midwest	539	510	384	356	167	147
East North Central	368	374	268	256	119	107
West North Central	172	136	116	100	48	40
South	941	984	652	638	269	287
South Atlantic	401	455	278	296	112	136
East South Central	173	164	119	109	58	45
West South Central	367	366	255	233	99	105
West	667	664	449	433	153	175
Mountain	209	229	139	166	53	67
Pacific	458	435	310	267	100	108
COUNTY TYPE
Large Metro	1,284	1,248	886	841	315	351
Small Metro	803	800	577	528	255	226
250K - 1 Mil. Pop.	546	537	396	364	171	157
< 250K Pop.	257	263	181	164	84	69
Nonmetro	435	433	286	272	118	116
Urbanized	184	217	123	123	53	54
Less Urbanized	214	175	137	114	54	48
Completely Rural	38	41	26	35	11	14

130328

Table 1.79B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	10.1	10.0	7.0	6.6	2.8	2.8
GEOGRAPHIC DIVISION
Northeast	8.8	7.6	6.2	5.1	2.3	2.0
New England	8.0	6.7	5.4	4.9	1.9	2.1
Middle Atlantic	9.0	8.0	6.4	5.1	2.4	1.9
Midwest	9.9	9.4	7.0	6.6	3.1	2.7
East North Central	9.7	9.9	7.0	6.8	3.1	2.8
West North Central	10.5	8.3	7.1	6.1	3.0	2.4
South	10.2	10.6	7.0	6.9	2.9	3.1
South Atlantic	8.7	9.8	6.0	6.4	2.4	2.9
East South Central	11.7	11.1	8.0	7.4	3.9	3.1
West South Central	11.6	11.5	8.1	7.3	3.1	3.3
West	11.1	11.1	7.5	7.3	2.6	2.9
Mountain	11.3	12.3	7.5	8.9	2.9	3.6
Pacific	11.0	10.6	7.5	6.5	2.4	2.6
COUNTY TYPE
Large Metro	9.6	9.2	6.7	6.2	2.4	2.6
Small Metro	10.2	10.8	7.4	7.1	3.3	3.1
250K - 1 Mil. Pop.	10.2	10.5	7.4	7.1	3.2	3.1
< 250K Pop.	10.4	11.4	7.3	7.1	3.4	3.0
Nonmetro	11.4	11.1	7.5	6.9	3.1	3.0
Urbanized	10.9	12.0	7.3	6.8	3.1	3.0
Less Urbanized	12.1	10.3	7.7	6.7	3.0	2.9
Completely Rural	10.6	10.0	7.4	8.4	3.2	3.3

130328

Table 1.80A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	9,373	9,709	4,366^a	4,729	1,711	1,832
GEOGRAPHIC DIVISION
Northeast	1,452^a	1,637	752^a	876	285	362
New England	435	480	227	238	89	101
Middle Atlantic	1,017^a	1,157	525^a	638	196	261
Midwest	2,031	2,072	987	969	401	338
East North Central	1,411	1,448	695	687	292	265
West North Central	619	624	293	283	109^a	72
South	3,465	3,541	1,554	1,693	614	694
South Atlantic	1,731	1,782	761	876	290	351
East South Central	608	540	287	257	131	124
West South Central	1,126	1,220	506	561	192	219
West	2,425	2,459	1,072	1,190	411	438
Mountain	818	777	390	342	129	133
Pacific	1,607	1,682	682^a	848	283	305
COUNTY TYPE
Large Metro	4,754^b	5,352	2,221^b	2,687	886^a	1,056
Small Metro	3,273	3,074	1,526	1,490	598	554
250K - 1 Mil. Pop.	2,112	1,940	975	932	352	357
< 250K Pop.	1,161	1,134	551	558	247	197
Nonmetro	1,346	1,283	619	552	227	223
Urbanized	698	618	324	242	111	91
Less Urbanized	546	554	258	259	104	115
Completely Rural	102	111	37	51	12	16

130328

Table 1.80B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	27.3	28.1	12.7^a	13.7	5.0	5.3
GEOGRAPHIC DIVISION
Northeast	23.7^a	26.6	12.3^a	14.2	4.7	5.9
New England	27.1	29.6	14.2	14.7	5.5	6.2
Middle Atlantic	22.5	25.5	11.6^a	14.1	4.3	5.8
Midwest	27.7	28.1	13.5	13.2	5.5	4.6
East North Central	27.9	28.5	13.7	13.5	5.8	5.2
West North Central	27.2	27.3	12.9	12.4	4.8^a	3.2
South	27.5	27.8	12.3	13.3	4.9	5.4
South Atlantic	26.9	27.3	11.8	13.4	4.5	5.4
East South Central	30.3	26.7	14.3	12.7	6.5	6.1
West South Central	27.1	29.0	12.2	13.3	4.6	5.2
West	29.5	29.6	13.0	14.3	5.0	5.3
Mountain	33.1	31.1	15.8	13.7	5.2	5.4
Pacific	27.9	28.9	11.8^a	14.6	4.9	5.2
COUNTY TYPE
Large Metro	25.8^b	28.3	12.1^b	14.2	4.8	5.6
Small Metro	29.4	28.4	13.7	13.8	5.4	5.1
250K - 1 Mil. Pop.	29.8	28.2	13.8	13.5	5.0	5.2
< 250K Pop.	28.6	28.9	13.6	14.2	6.1	5.0
Nonmetro	28.4	26.5	13.0	11.4	4.8	4.6
Urbanized	31.6	27.8	14.7^a	10.9	5.0	4.1
Less Urbanized	26.1	25.4	12.3	11.9	5.0	5.3
Completely Rural	23.0	24.9	8.3	11.4	2.6	3.6

130328

Table 1.81A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	39,348^b	42,198	8,542^b	10,296	3,720	4,306
GEOGRAPHIC DIVISION
Northeast	6,704	7,155	1,450	1,647	664	609
New England	1,826	2,045	403	393	168	152
Middle Atlantic	4,878	5,110	1,047	1,254	496	457
Midwest	8,115	8,463	1,772	2,046	825	818
East North Central	5,750	6,236	1,309	1,542	629	667
West North Central	2,365	2,227	463	504	196	151
South	14,014	14,514	3,128^a	3,744	1,262^a	1,679
South Atlantic	7,384	7,755	1,613	1,739	573	762
East South Central	2,313	2,251	522	693	233	322
West South Central	4,317	4,509	993^a	1,313	457	595
West	10,514^b	12,067	2,192^a	2,858	969	1,199
Mountain	3,378	3,625	711	846	287	339
Pacific	7,136^a	8,442	1,481^a	2,012	682	860
COUNTY TYPE
Large Metro	21,002^b	23,480	4,565^b	5,892	1,835^a	2,465
Small Metro	12,758	12,997	2,741	2,972	1,268	1,341
250K - 1 Mil. Pop.	9,034	9,070	1,836	2,082	875	979
< 250K Pop.	3,724	3,927	905	890	393	362
Nonmetro	5,588	5,722	1,236	1,433	616	500
Urbanized	2,516	2,809	654	697	321	249
Less Urbanized	2,436	2,356	478	637	247	215
Completely Rural	635	557	105	99	49	36

130328

Table 1.81B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	19.8^a	21.0	4.3^b	5.1	1.9	2.1
GEOGRAPHIC DIVISION
Northeast	18.4	19.5	4.0	4.5	1.8	1.7
New England	19.0	21.1	4.2	4.1	1.7	1.6
Middle Atlantic	18.1	18.9	3.9	4.6	1.8	1.7
Midwest	18.9	19.6	4.1	4.7	1.9	1.9
East North Central	19.3	20.8	4.4	5.1	2.1	2.2
West North Central	18.1	16.9	3.5	3.8	1.5	1.1
South	19.1	19.5	4.3	5.0	1.7^a	2.3
South Atlantic	18.9	19.5	4.1	4.4	1.5	1.9
East South Central	19.6	18.9	4.4	5.8	2.0	2.7
West South Central	19.3	19.8	4.4	5.8	2.0	2.6
West	23.1^a	26.1	4.8^a	6.2	2.1	2.6
Mountain	24.4	25.8	5.1	6.0	2.1	2.4
Pacific	22.5^a	26.2	4.7^a	6.2	2.1	2.7
COUNTY TYPE
Large Metro	20.0^a	22.0	4.3^b	5.5	1.7^a	2.3
Small Metro	20.7	21.6	4.4	4.9	2.1	2.2
250K - 1 Mil. Pop.	21.5	22.2	4.4	5.1	2.1	2.4
< 250K Pop.	19.0	20.3	4.6	4.6	2.0	1.9
Nonmetro	17.7	17.1	3.9	4.3	1.9	1.5
Urbanized	19.5	19.4	5.1	4.8	2.5	1.7
Less Urbanized	15.9	15.6	3.1	4.2	1.6	1.4
Completely Rural	18.7	14.3	3.1	2.5	1.4	0.9

130328

Table 1.82A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	48,721^b	51,908	12,908^b	15,025	5,431^a	6,138
GEOGRAPHIC DIVISION
Northeast	8,157	8,792	2,202	2,523	949	971
New England	2,261	2,525	631	631	257	254
Middle Atlantic	5,896	6,267	1,571	1,892	692	718
Midwest	10,146	10,535	2,760	3,016	1,226	1,156
East North Central	7,161	7,685	2,004	2,229	921	932
West North Central	2,985	2,850	756	787	305	224
South	17,479	18,055	4,682^a	5,438	1,876^a	2,374
South Atlantic	9,114	9,536	2,374	2,615	863	1,113
East South Central	2,921	2,791	809	950	364	447
West South Central	5,443	5,728	1,499^a	1,873	649	814
West	12,939^b	14,525	3,264^b	4,048	1,380	1,637
Mountain	4,196	4,401	1,101	1,188	415	472
Pacific	8,743^b	10,124	2,163^b	2,860	965	1,165
COUNTY TYPE
Large Metro	25,756^b	28,833	6,786^b	8,579	2,721^b	3,520
Small Metro	16,031	16,070	4,267	4,461	1,866	1,895
250K - 1 Mil. Pop.	11,146	11,010	2,811	3,013	1,227	1,336
< 250K Pop.	4,885	5,061	1,456	1,448	640	559
Nonmetro	6,934	7,005	1,855	1,984	843	723
Urbanized	3,214	3,427	978	939	432	340
Less Urbanized	2,982	2,909	736	896	351	330
Completely Rural	737	668	142	150	60	53

130328

Table 1.82B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
Low precision; no estimate reported. NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs. NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.* ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	20.9^a	22.1	5.5^b	6.4	2.3	2.6
GEOGRAPHIC DIVISION
Northeast	19.1	20.5	5.2	5.9	2.2	2.3
New England	20.2	22.3	5.6	5.6	2.3	2.2
Middle Atlantic	18.8	19.8	5.0	6.0	2.2	2.3
Midwest	20.2	20.9	5.5	6.0	2.4	2.3
East North Central	20.5	21.9	5.7	6.4	2.6	2.7
West North Central	19.4	18.4	4.9	5.1	2.0	1.4
South	20.3	20.7	5.4^a	6.2	2.2^a	2.7
South Atlantic	20.0	20.6	5.2	5.7	1.9	2.4
East South Central	21.1	20.0	5.8	6.8	2.6	3.2
West South Central	20.5	21.3	5.6^a	7.0	2.4	3.0
West	24.0^a	26.6	6.1^a	7.4	2.6	3.0
Mountain	25.7	26.6	6.7	7.2	2.5	2.9
Pacific	23.3^a	26.6	5.8^a	7.5	2.6	3.1
COUNTY TYPE
Large Metro	20.9^b	22.9	5.5^b	6.8	2.2^b	2.8
Small Metro	22.0	22.6	5.9	6.3	2.6	2.7
250K - 1 Mil. Pop.	22.7	23.0	5.7	6.3	2.5	2.8
< 250K Pop.	20.7	21.7	6.2	6.2	2.7	2.4
Nonmetro	19.1	18.3	5.1	5.2	2.3	1.9
Urbanized	21.3	20.6	6.5	5.6	2.9	2.0
Less Urbanized	17.1	16.8	4.2	5.2	2.0	1.9
Completely Rural	19.2	15.3	3.7	3.4	1.6	1.2

130328

Table 1.83A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	34,247^b	37,045	11,143^b	12,489	4,471	4,862
GEOGRAPHIC DIVISION
Northeast	5,415^a	6,090	1,858	1,930	757	772
New England	1,560	1,748	491	459	220	197
Middle Atlantic	3,855	4,342	1,367	1,471	537	575
Midwest	7,375	7,712	2,498	2,591	1,086	1,025
East North Central	5,348	5,721	1,857	1,970	868	818
West North Central	2,026	1,990	641	621	218	207
South	12,528	13,056	3,992^a	4,583	1,512^a	1,893
South Atlantic	6,227	6,637	1,916	2,284	621^b	946
East South Central	2,124	2,310	708	817	327	354
West South Central	4,177	4,109	1,368	1,481	563	593
West	8,929^b	10,187	2,795^a	3,386	1,116	1,172
Mountain	2,881	2,994	954	925	332	348
Pacific	6,049^b	7,193	1,842^b	2,461	784	823
COUNTY TYPE
Large Metro	17,755^b	20,563	5,715^b	7,042	2,140^b	2,737
Small Metro	11,417	11,341	3,862	3,720	1,621	1,481
250K - 1 Mil. Pop.	7,817	7,679	2,571	2,488	1,081	1,009
< 250K Pop.	3,600	3,663	1,291	1,232	540	472
Nonmetro	5,075	5,141	1,566	1,727	710	644
Urbanized	2,397	2,599	792	843	348	266
Less Urbanized	2,215	2,086	652	743	297	320
Completely Rural	463	456	123	142	64	58

130328

Table 1.83B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	13.3^b	14.2	4.3^b	4.8	1.7	1.9
GEOGRAPHIC DIVISION
Northeast	11.5	12.9	4.0	4.1	1.6	1.6
New England	12.7	14.1	4.0	3.7	1.8	1.6
Middle Atlantic	11.2	12.5	4.0	4.2	1.6	1.7
Midwest	13.2	13.8	4.5	4.6	1.9	1.8
East North Central	13.8	14.7	4.8	5.1	2.2	2.1
West North Central	11.9	11.6	3.8	3.6	1.3	1.2
South	13.2	13.5	4.2^a	4.8	1.6^a	2.0
South Atlantic	12.4	13.1	3.8	4.5	1.2^b	1.9
East South Central	13.9	15.0	4.6	5.3	2.1	2.3
West South Central	14.1	13.6	4.6	4.9	1.9	2.0
West	14.9^a	16.8	4.7^a	5.6	1.9	1.9
Mountain	15.9	16.3	5.3	5.0	1.8	1.9
Pacific	14.5^a	17.1	4.4^b	5.8	1.9	2.0
COUNTY TYPE
Large Metro	13.0^b	14.8	4.2^b	5.1	1.6^a	2.0
Small Metro	14.2	14.4	4.8	4.7	2.0	1.9
250K - 1 Mil. Pop.	14.3	14.5	4.7	4.7	2.0	1.9
< 250K Pop.	13.8	14.3	4.9	4.8	2.1	1.8
Nonmetro	12.6	12.2	3.9	4.1	1.8	1.5
Urbanized	14.3	14.1	4.7	4.6	2.1	1.4
Less Urbanized	11.5	11.0	3.4	3.9	1.6	1.7
Completely Rural	11.0	9.6	2.9	3.0	1.5	1.2

130328

Table 1.84A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	2,150	2,069	1,484^a	1,333	563	558
GEOGRAPHIC DIVISION
Northeast	326^a	255	229^b	166	86	66
New England	74	62	51	43	19	20
Middle Atlantic	252^a	193	178^b	123	66	46
Midwest	463	429	326	288	141	118
East North Central	318	318	231	212	98	87
West North Central	144	110	95	76	44	32
South	768	814	534	506	203	226
South Atlantic	316	373	222	232	80	103
East South Central	145	140	107	88	48	39
West South Central	307	301	205	186	75	84
West	593	571	395	373	133	148
Mountain	187	192	123	145	45	58
Pacific	406	379	271	227	89	89
COUNTY TYPE
Large Metro	1,087	1,033	752	678	252	275
Small Metro	694	677	494	436	209	186
250K - 1 Mil. Pop.	479	461	348	301	139	127
< 250K Pop.	215	216	146	135	69	59
Nonmetro	369	358	238	219	102	97
Urbanized	158	174	100	95	47	44
Less Urbanized	180	151	115	98	46	44
Completely Rural	31	33	23	27	8	9

130328

Table 1.84B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	8.6	8.3	5.9^a	5.3	2.3	2.2
GEOGRAPHIC DIVISION
Northeast	7.6^a	6.0	5.4^b	3.9	2.0	1.6
New England	6.7	5.6	4.6	3.9	1.7	1.8
Middle Atlantic	8.0^a	6.2	5.6^b	3.9	2.1	1.5
Midwest	8.5	7.9	6.0	5.3	2.6	2.2
East North Central	8.4	8.4	6.1	5.6	2.6	2.3
West North Central	8.8	6.7	5.8	4.6	2.7	1.9
South	8.3	8.7	5.8	5.4	2.2	2.4
South Atlantic	6.8	8.0	4.8	5.0	1.7	2.2
East South Central	9.8	9.4	7.2	6.0	3.3	2.6
West South Central	9.7	9.5	6.5	5.8	2.4	2.6
West	9.9	9.6	6.6	6.2	2.2	2.5
Mountain	10.2	10.3	6.7	7.8	2.4	3.1
Pacific	9.8	9.2	6.5	5.5	2.1	2.2
COUNTY TYPE
Large Metro	8.2	7.6	5.6	5.0	1.9	2.0
Small Metro	8.9	9.1	6.3	5.9	2.7	2.5
250K - 1 Mil. Pop.	8.9	9.0	6.5	5.9	2.6	2.5
< 250K Pop.	8.7	9.4	5.9	5.9	2.8	2.6
Nonmetro	9.6	9.1	6.2	5.6	2.7	2.5
Urbanized	9.3	9.6	5.9	5.2	2.8	2.4
Less Urbanized	10.1	8.9	6.5	5.8	2.6	2.6
Completely Rural	8.7	7.9	6.5	6.4	2.3	2.2

130328

Table 1.85A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	7,600	7,759	3,353	3,507	1,220	1,311
GEOGRAPHIC DIVISION
Northeast	1,149	1,254	547	581	194	250
New England	363	371	164	147	60	66
Middle Atlantic	786	884	382	434	134	183
Midwest	1,712	1,611	758	716	305	255
East North Central	1,200	1,168	544	529	230	208
West North Central	512	443	214	188	74	47
South	2,739	2,841	1,167	1,297	405	496
South Atlantic	1,322	1,402	552	653	163^a	258
East South Central	518	477	233	214	113	89
West South Central	899	962	383	429	129	149
West	2,000	2,052	881	913	316	311
Mountain	670	660	315	267	92	98
Pacific	1,330	1,392	566	645	224	213
COUNTY TYPE
Large Metro	3,791^a	4,239	1,703^a	1,960	623	762
Small Metro	2,681	2,449	1,172	1,111	419	376
250K - 1 Mil. Pop.	1,727	1,545	749	707	242	244
< 250K Pop.	953	904	423	404	177	133
Nonmetro	1,128	1,071	478	436	178	172
Urbanized	590	506	242	189	82	69
Less Urbanized	458	471	208	207	86	92
Completely Rural	81	94	28	40	11	12

130328

Table 1.85B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	22.2	22.4	9.8	10.1	3.6	3.8
GEOGRAPHIC DIVISION
Northeast	18.8	20.4	8.9	9.4	3.2	4.1
New England	22.6	22.9	10.2	9.1	3.7	4.1
Middle Atlantic	17.4	19.5	8.5	9.6	3.0	4.0
Midwest	23.3	21.9	10.3	9.7	4.1	3.5
East North Central	23.7	23.0	10.7	10.4	4.5	4.1
West North Central	22.5	19.4	9.4	8.2	3.3	2.0
South	21.7	22.3	9.3	10.2	3.2	3.9
South Atlantic	20.5	21.5	8.6	10.0	2.5^a	3.9
East South Central	25.8	23.6	11.6	10.6	5.6	4.4
West South Central	21.6	22.8	9.2	10.2	3.1	3.6
West	24.3	24.7	10.7	11.0	3.8	3.7
Mountain	27.1	26.5	12.8	10.7	3.7	3.9
Pacific	23.1	23.9	9.8	11.1	3.9	3.7
COUNTY TYPE
Large Metro	20.6^a	22.4	9.3^a	10.4	3.4	4.0
Small Metro	24.0	22.7	10.5	10.3	3.8	3.5
250K - 1 Mil. Pop.	24.4	22.4	10.6	10.3	3.4	3.5
< 250K Pop.	23.5	23.1	10.4	10.3	4.4	3.4
Nonmetro	23.8	22.1	10.1	9.0	3.8	3.6
Urbanized	26.7	22.8	11.0	8.5	3.7	3.1
Less Urbanized	21.9	21.6	9.9	9.5	4.1	4.2
Completely Rural	18.3	21.0	6.4	9.0	2.4	2.6

130328

Table 1.86A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	24,497^b	27,218	6,306^b	7,649	2,688	2,993
GEOGRAPHIC DIVISION
Northeast	3,940^a	4,581	1,082	1,182	477	457
New England	1,122	1,316	275	268	141	111
Middle Atlantic	2,817	3,265	806	914	337	346
Midwest	5,200	5,672	1,414	1,587	640	652
East North Central	3,830	4,235	1,082	1,229	540	523
West North Central	1,370	1,437	332	358	100	128
South	9,021	9,402	2,291	2,780	903	1,171
South Atlantic	4,589	4,863	1,141	1,399	378	586
East South Central	1,461	1,693	369	514	166	227
West South Central	2,970	2,846	781	866	359	359
West	6,336^b	7,564	1,520^b	2,100	667	713
Mountain	2,023	2,142	515	512	196	192
Pacific	4,313^b	5,421	1,005^b	1,588	471	521
COUNTY TYPE
Large Metro	12,877^b	15,291	3,261^b	4,405	1,265^a	1,700
Small Metro	8,042	8,215	2,195	2,172	994	919
250K - 1 Mil. Pop.	5,611	5,673	1,473	1,480	700	639
< 250K Pop.	2,431	2,542	722	692	294	280
Nonmetro	3,578	3,712	850	1,072	430	375
Urbanized	1,649	1,918	450	559	219	153
Less Urbanized	1,578	1,464	329	438	166	185
Completely Rural	351	329	71	75	46	36

130328

Table 1.86B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	12.4^b	13.6	3.2^b	3.8	1.4	1.5
GEOGRAPHIC DIVISION
Northeast	10.8	12.5	3.0	3.2	1.3	1.2
New England	11.7	13.6	2.9	2.8	1.5	1.1
Middle Atlantic	10.5	12.0	3.0	3.4	1.3	1.3
Midwest	12.1	13.1	3.3	3.7	1.5	1.5
East North Central	12.8	14.1	3.6	4.1	1.8	1.7
West North Central	10.5	10.9	2.5	2.7	0.8	1.0
South	12.3	12.7	3.1	3.7	1.2	1.6
South Atlantic	11.7	12.3	2.9	3.5	1.0	1.5
East South Central	12.4	14.2	3.1	4.3	1.4	1.9
West South Central	13.3	12.5	3.5	3.8	1.6	1.6
West	13.9^a	16.3	3.3^a	4.5	1.5	1.5
Mountain	14.6	15.2	3.7	3.6	1.4	1.4
Pacific	13.6^a	16.8	3.2^b	4.9	1.5	1.6
COUNTY TYPE
Large Metro	12.3^b	14.3	3.1^b	4.1	1.2	1.6
Small Metro	13.1	13.6	3.6	3.6	1.6	1.5
250K - 1 Mil. Pop.	13.3	13.9	3.5	3.6	1.7	1.6
< 250K Pop.	12.4	13.1	3.7	3.6	1.5	1.4
Nonmetro	11.3	11.1	2.7	3.2	1.4	1.1
Urbanized	12.8	13.3	3.5	3.9	1.7	1.1
Less Urbanized	10.3	9.7	2.1	2.9	1.1	1.2
Completely Rural	10.3	8.4	2.1	1.9	1.3	0.9

130328

Table 1.87A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	32,097^b	34,977	9,659^b	11,157	3,908	4,304
GEOGRAPHIC DIVISION
Northeast	5,089^a	5,835	1,628	1,763	672	706
New England	1,485	1,686	440	415	201	177
Middle Atlantic	3,603	4,149	1,188	1,348	471	529
Midwest	6,912	7,283	2,172	2,303	945	906
East North Central	5,030	5,403	1,626	1,758	770	731
West North Central	1,882	1,880	545	545	174	175
South	11,759	12,242	3,458^a	4,077	1,309^a	1,667
South Atlantic	5,911	6,264	1,693	2,052	541^b	843
East South Central	1,979	2,170	602	729	279	315
West South Central	3,869	3,808	1,163	1,296	489	508
West	8,336^b	9,616	2,401^b	3,013	983	1,024
Mountain	2,693	2,802	830	780	287	290
Pacific	5,643^b	6,814	1,570^b	2,233	695	734
COUNTY TYPE
Large Metro	16,668^b	19,530	4,964^b	6,365	1,888^b	2,462
Small Metro	10,722	10,664	3,367	3,284	1,412	1,295
250K - 1 Mil. Pop.	7,338	7,218	2,223	2,187	941	882
< 250K Pop.	3,384	3,447	1,145	1,097	471	413
Nonmetro	4,706	4,783	1,328	1,508	608	547
Urbanized	2,239	2,424	692	748	300	222
Less Urbanized	2,035	1,935	537	645	251	277
Completely Rural	432	423	99	115	56	48

130328

Table 1.87B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2011 and 2012
Geographic Characteristic	Lifetime (2011)	Lifetime (2012)	Past Year (2011)	Past Year (2012)	Past Month (2011)	Past Month (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
TOTAL	13.8^b	14.9	4.2^b	4.7	1.7	1.8
GEOGRAPHIC DIVISION
Northeast	11.9^a	13.6	3.8	4.1	1.6	1.6
New England	13.3	14.9	3.9	3.7	1.8	1.6
Middle Atlantic	11.5	13.1	3.8	4.3	1.5	1.7
Midwest	13.8	14.4	4.3	4.6	1.9	1.8
East North Central	14.4	15.4	4.7	5.0	2.2	2.1
West North Central	12.3	12.2	3.6	3.5	1.1	1.1
South	13.7	14.1	4.0^a	4.7	1.5^a	1.9
South Atlantic	13.0	13.6	3.7	4.4	1.2^a	1.8
East South Central	14.3	15.6	4.4	5.2	2.0	2.3
West South Central	14.6	14.1	4.4	4.8	1.8	1.9
West	15.5^a	17.6	4.5^a	5.5	1.8	1.9
Mountain	16.5	16.9	5.1	4.7	1.8	1.8
Pacific	15.0^b	17.9	4.2^b	5.9	1.9	1.9
COUNTY TYPE
Large Metro	13.5^b	15.5	4.0^b	5.1	1.5^a	2.0
Small Metro	14.7	15.0	4.6	4.6	1.9	1.8
250K - 1 Mil. Pop.	14.9	15.1	4.5	4.6	1.9	1.8
< 250K Pop.	14.3	14.8	4.8	4.7	2.0	1.8
Nonmetro	12.9	12.5	3.7	3.9	1.7	1.4
Urbanized	14.8	14.5	4.6	4.5	2.0	1.3
Less Urbanized	11.7	11.2	3.1	3.7	1.4	1.6
Completely Rural	11.2	9.7	2.6	2.6	1.5	1.1

130329

Table 1.88A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Numbers in Thousands, 2011 and 2012
Drug or Method of Administration	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. ² These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview. ³ Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings*. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
HALLUCINOGENS	36,362	37,908	930	823	6,029	6,103	29,403	30,982
PCP (Angel Dust, Phencyclidine)	6,103	6,552	76	96	351	345	5,676	6,112
LSD (Acid)	23,000	23,735	229	249	2,054	2,056	20,716	21,430
Peyote	5,257	5,925	45	48	283	316	4,929	5,561
Mescaline	7,840	7,891	23	28	376	336	7,440	7,527
Psilocybin (Mushrooms)	20,881	20,989	339	319	3,480	3,226	17,063	17,445
Ecstasy (MDMA)	14,570^b	16,162	605^a	488	4,222	4,452	9,743^b	11,222
INHALANTS	20,523	21,095	1,877^b	1,613	3,106	2,918	15,540	16,563
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush	7,017	6,729	304^a	228	590	498	6,124	6,002
Correction Fluid, Degreaser, or Cleaning Fluid	1,841	1,709	351	332	299	238	1,190	1,139
Gasoline or Lighter Fluid	3,295	3,375	579	535	443	455	2,272	2,385
Glue, Shoe Polish, or Toluene	3,347	3,118	648	582	401	378	2,298	2,158
Halothane, Ether, or Other Anesthetics	980	858	85^a	44	145	112	750	702
Lacquer Thinner or Other Paint Solvents	1,746	1,559	255	245	247	202	1,243	1,113
Lighter Gases (Butane, Propane)	734	771	170	156	115	100	449	515
Nitrous Oxide or Whippits	11,263	12,139	240	189	1,893	1,812	9,131^a	10,138
Spray Paints	2,087	1,755	634^a	532	351	301	1,102	922
Other Aerosol Sprays	2,145	2,113	397^a	321	610^a	494	1,138	1,299
NEEDLE USE^1,2,3	3,639	4,039	48	47	383	466	3,208	3,526
Heroin Needle Use^1,2	1,846	2,079	21	21	224	292	1,602	1,767
Cocaine Needle Use^1,2	1,957	2,027	10	6	135	154	1,812	1,867
Stimulant Needle Use^1,2,3	1,619	1,821	26	16	165	160	1,427	1,646
Methamphetamine Needle Use^1,2,3	1,345	1,589	21	11	107	130	1,217	1,448
HEROIN	4,162	4,565	70	59	594	664	3,499	3,841
Smoke Heroin²	1,402	1,760	36	27	260	320	1,106	1,412
Sniff or Snort Heroin²	2,964	3,276	37	18	400	467	2,527	2,790

130329

Table 1.88B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Percentages, 2011 and 2012
Drug or Method of Administration	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused. ² These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview. ³ Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings*. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
HALLUCINOGENS	14.1	14.6	3.7	3.3	17.6	17.6	14.8	15.4
PCP (Angel Dust, Phencyclidine)	2.4	2.5	0.3	0.4	1.0	1.0	2.9	3.0
LSD (Acid)	8.9	9.1	0.9	1.0	6.0	5.9	10.4	10.7
Peyote	2.0	2.3	0.2	0.2	0.8	0.9	2.5	2.8
Mescaline	3.0	3.0	0.1	0.1	1.1	1.0	3.8	3.8
Psilocybin (Mushrooms)	8.1	8.1	1.4	1.3	10.1^a	9.3	8.6	8.7
Ecstasy (MDMA)	5.7^b	6.2	2.4^a	2.0	12.3	12.9	4.9^b	5.6
INHALANTS	8.0	8.1	7.5^b	6.5	9.1	8.4	7.8	8.3
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush	2.7	2.6	1.2^a	0.9	1.7	1.4	3.1	3.0
Correction Fluid, Degreaser, or Cleaning Fluid	0.7	0.7	1.4	1.3	0.9	0.7	0.6	0.6
Gasoline or Lighter Fluid	1.3	1.3	2.3	2.1	1.3	1.3	1.1	1.2
Glue, Shoe Polish, or Toluene	1.3	1.2	2.6	2.3	1.2	1.1	1.2	1.1
Halothane, Ether, or Other Anesthetics	0.4	0.3	0.3^a	0.2	0.4	0.3	0.4	0.4
Lacquer Thinner or Other Paint Solvents	0.7	0.6	1.0	1.0	0.7	0.6	0.6	0.6
Lighter Gases (Butane, Propane)	0.3	0.3	0.7	0.6	0.3	0.3	0.2	0.3
Nitrous Oxide or Whippits	4.4	4.7	1.0	0.8	5.5	5.2	4.6	5.1
Spray Paints	0.8	0.7	2.5^a	2.1	1.0	0.9	0.6	0.5
Other Aerosol Sprays	0.8	0.8	1.6^a	1.3	1.8^a	1.4	0.6	0.6
NEEDLE USE^1,2,3	1.4	1.6	0.2	0.2	1.1	1.3	1.6	1.8
Heroin Needle Use^1,2	0.7	0.8	0.1	0.1	0.7	0.8	0.8	0.9
Cocaine Needle Use^1,2	0.8	0.8	0.0	0.0	0.4	0.4	0.9	0.9
Stimulant Needle Use^1,2,3	0.6	0.7	0.1	0.1	0.5	0.5	0.7	0.8
Methamphetamine Needle Use^1,2,3	0.5	0.6	0.1	0.0	0.3	0.4	0.6	0.7
HEROIN	1.6	1.8	0.3	0.2	1.7	1.9	1.8	1.9
Smoke Heroin²	0.5	0.7	0.1	0.1	0.8	0.9	0.6	0.7
Sniff or Snort Heroin²	1.2	1.3	0.1	0.1	1.2	1.4	1.3	1.4

130329

Table 1.89A – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Numbers in Thousands, 2011 and 2012
Pain Reliever	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	16,507^a	18,079	900	837	2,767	2,808	12,840^b	14,435
Percocet^®, Percodan^®, or Tylox^®	12,910^a	14,136	422	361	3,059	3,012	9,429^b	10,763
Vicodin^®, Lortab^®, or Lorcet^®	21,262^b	23,731	948	850	5,511	5,548	14,803^b	17,332
Codeine	6,407	6,825	365	335	1,790	1,694	4,252	4,796
Demerol^®	1,851	1,901	42	42	294	287	1,515	1,572
Dilaudid^®	1,008^b	1,762	9	12	257	334	742^b	1,417
Fioricet^®	441	359	21	9	49	58	370	291
Fiorinal^®	224	249	25	16	32	32	167	200
Hydrocodone	9,779^b	11,416	451^a	371	2,884	3,034	6,444^b	8,011
Methadone	2,104	2,460	150^a	98	761	737	1,192^a	1,625
Morphine	2,696^b	3,587	188	179	963	1,098	1,546^b	2,310
OxyContin^®	5,917^a	6,579	369	322	2,079	2,011	3,469^a	4,247
Phenaphen^® with Codeine	599	625	52	48	170	157	377	420
Propoxyphene	255	269	17	29	54	60	183	180
SK-65^®	25	42	7	15	18	18	*	*
Stadol^®	102	105	3	5	2	17	97	84
Talacen^®	57	50	8	12	7	11	42	26
Talwin^®	192	232	10	17	*	22	180	193
Talwin^® NX	55	122	12	4	5	15	39	102
Tramadol	2,165^b	2,719	144^b	87	712^a	857	1,309^a	1,775
Ultram^®	1,155	1,299	32	32	263	234	860	1,033
SELECTED GROUPS OF DRUGS¹
Propoxyphene or Codeine Products²	18,465^a	20,058	1,066	1,014	3,481	3,463	13,917^b	15,581
Oxycodone Products³	14,817^a	16,027	643	562	3,777	3,678	10,397^b	11,788
Hydrocodone Products⁴	23,226^b	25,675	1,114	1,014	6,037	6,086	16,075^b	18,575
Tramadol Products⁵	2,614^b	3,233	159^b	101	794	914	1,660^b	2,218

130329

Table 1.89B – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Percentages, 2011 and 2012
Pain Reliever	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category. ² Includes Darvocet^®, Darvon^® or Tylenol^® with Codeine, codeine, Phenaphen^® with Codeine, propoxyphene, and SK-65^®. ³ Includes Percocet^®, Percodan^® or Tylox^®, and OxyContin^®. ⁴ Includes Vicodin^®, Lortab^®, or Lorcet^®, and hydrocodone. ⁵ Includes tramadol and Ultram^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Darvocet^®, Darvon^®, or Tylenol^® with Codeine	6.4^a	7.0	3.6	3.4	8.1	8.1	6.5^a	7.2
Percocet^®, Percodan^®, or Tylox^®	5.0^a	5.4	1.7	1.4	8.9	8.7	4.8^a	5.4
Vicodin^®, Lortab^®, or Lorcet^®	8.3^b	9.1	3.8	3.4	16.1	16.0	7.5^b	8.6
Codeine	2.5	2.6	1.5	1.3	5.2	4.9	2.1	2.4
Demerol^®	0.7	0.7	0.2	0.2	0.9	0.8	0.8	0.8
Dilaudid^®	0.4^b	0.7	0.0	0.0	0.7	1.0	0.4^b	0.7
Fioricet^®	0.2	0.1	0.1	0.0	0.1	0.2	0.2	0.1
Fiorinal^®	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Hydrocodone	3.8^b	4.4	1.8^a	1.5	8.4	8.8	3.2^b	4.0
Methadone	0.8	0.9	0.6^a	0.4	2.2	2.1	0.6^a	0.8
Morphine	1.0^b	1.4	0.8	0.7	2.8	3.2	0.8^b	1.2
OxyContin^®	2.3	2.5	1.5	1.3	6.1	5.8	1.7^a	2.1
Phenaphen^® with Codeine	0.2	0.2	0.2	0.2	0.5	0.5	0.2	0.2
Propoxyphene	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1
SK-65^®	0.0	0.0	0.0	0.1	0.1	0.1	*	*
Stadol^®	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Talacen^®	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Talwin^®	0.1	0.1	0.0	0.1	*	0.1	0.1	0.1
Talwin^® NX	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
Tramadol	0.8^a	1.0	0.6^b	0.4	2.1^a	2.5	0.7^a	0.9
Ultram^®	0.4	0.5	0.1	0.1	0.8	0.7	0.4	0.5
SELECTED GROUPS OF DRUGS¹
Propoxyphene or Codeine Products²	7.2^a	7.7	4.3	4.1	10.1	10.0	7.0^a	7.8
Oxycodone Products³	5.8	6.2	2.6	2.3	11.0	10.6	5.2^a	5.9
Hydrocodone Products⁴	9.0^b	9.9	4.5	4.1	17.6	17.6	8.1^b	9.3
Tramadol Products⁵	1.0^b	1.2	0.6^b	0.4	2.3	2.6	0.8^a	1.1

130329

Table 1.90A – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Numbers in Thousands, 2011 and 2012
Tranquilizer	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^® or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Klonopin^® or Clonazepam	5,094^a	5,799	191	184	1,433	1,598	3,470	4,017
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	13,657^b	15,613	513	517	3,494	3,687	9,650^b	11,410
Valium^® or Diazepam	12,649	13,045	210	221	1,750	1,745	10,690	11,079
Atarax^®	128	236	10	13	30	53	88	170
BuSpar^®	694	732	25	20	196	167	474	545
Equanil^®	67	55	3	7	4	18	60	30
Flexeril^®	2,454^b	3,149	59	36	563	528	1,832^b	2,585
Librium^®	499	695	8	12	49	57	442	626
Limbitrol^®	54	62	6	11	10	21	37	31
Meprobamate	79	133	21	13	20	27	37	93
Miltown^®	38^a	161	7	7	5	24	26	130
Rohypnol^®	290	256	22	27	64	69	204	160
Serax^®	50	53	3	7	19	25	28	21
Soma^®	3,062^a	3,690	83	63	894	820	2,086^b	2,808
Tranxene^®	140	113	5	5	23	18	112	90
Vistaril^®	254	263	19	13	51	74	184	176
SELECTED GROUPS OF DRUGS¹
Benzodiazepines²	20,409^a	22,086	644	655	3,990	4,249	15,776^a	17,182
Meprobamate Products³	168	268	26	20	26	45	116	203
Muscle Relaxants⁴	4,623^b	5,530	115	85	1,188	1,119	3,320^b	4,326

130329

Table 1.90B – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Percentages, 2011 and 2012
Tranquilizer	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category. ² Includes Klonopin^® or clonazepam, Xanax^®, alprazolam, Ativan^® or lorazepam, Valium^® or diazepam, Librium^®, Limbitrol^®, Rohypnol^®, Serax^®, and Tranxene^®. ³ Includes Equanil^®, meprobamate, and Miltown^®. ⁴ Includes Flexeril^® and Soma^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Klonopin^® or Clonazepam	2.0^a	2.2	0.8	0.7	4.2	4.6	1.7	2.0
Xanax^®, Alprazolam, Ativan^®, or Lorazepam	5.3^b	6.0	2.1	2.1	10.2	10.7	4.9^b	5.7
Valium^® or Diazepam	4.9	5.0	0.8	0.9	5.1	5.0	5.4	5.5
Atarax^®	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.1
BuSpar^®	0.3	0.3	0.1	0.1	0.6	0.5	0.2	0.3
Equanil^®	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
Flexeril^®	1.0^b	1.2	0.2	0.1	1.6	1.5	0.9^b	1.3
Librium^®	0.2	0.3	0.0	0.0	0.1	0.2	0.2	0.3
Limbitrol^®	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
Meprobamate	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0
Miltown^®	0.0^a	0.1	0.0	0.0	0.0	0.1	0.0	0.1
Rohypnol^®	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1
Serax^®	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
Soma^®	1.2^a	1.4	0.3	0.3	2.6	2.4	1.1^b	1.4
Tranxene^®	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0
Vistaril^®	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1
SELECTED GROUPS OF DRUGS¹
Benzodiazepines²	7.9^a	8.5	2.6	2.6	11.6	12.3	8.0	8.6
Meprobamate Products³	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
Muscle Relaxants⁴	1.8^b	2.1	0.5	0.3	3.5	3.2	1.7^b	2.2

130329

Table 1.91A – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Numbers in Thousands, 2011 and 2012
Stimulant	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn^®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings*. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. ⁶ Includes Ritalin^®, other products containing methylphenidate, and products containing dexmethylphenidate. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methamphetamine, Desoxyn^®, or Methedrine¹	11,928	12,259	184	145	1,150	1,089	10,594	11,025
Prescription Diet Pills²	6,586	7,246	112	125	582^a	729	5,892	6,391
Ritalin^® or Methylphenidate	4,918^b	6,008	245	242	1,687	1,790	2,986^b	3,976
Cylert^®	126	112	8	8	34	22	84	82
Dexedrine^®	1,898	1,689	10	14	100	100	1,788	1,575
Dextroamphetamine	734	770	29	18	164	193	541	558
Didrex^®	133	97	5	3	21	9	107	85
Eskatrol^®	40	148	5	6	6	14	28	128
Ionamin^®	335	300	3	4	12	3	319	294
Mazanor^®	47	38	3	10	7	11	37	17
Obedrin-LA^®	*	20	7	5	*	*	*	14
Plegine^®	17	26	*	5	4	6	13	15
Preludin^®	301	335	3	6	21	19	276	310
Sanorex^®	79	40	4	14	14	6	60	20
Tenuate^®	156	100	6	2	7	10	143	88
SELECTED GROUPS OF DRUGS³
Amphetamine, Dextroamphetamine, and Phentermine Products⁴	8,784	9,400	200	232	1,302^a	1,519	7,283	7,650
Mazindol Products⁵	114	74	7^a	22	18	15	88	37
Methylphenidate or Dexmethylphenidate Products⁶	4,931^b	6,050	252	245	1,693	1,816	2,986^b	3,990

130329

Table 1.91B – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Percentages, 2011 and 2012
Stimulant	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn^®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings*. ² Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine^®, Biphetamine^®, Fastin^®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills. ³ Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category. ⁴ Includes prescription diet pills, Dexedrine^®, dextroamphetamine, and Ionamin^®. ⁵ Includes Mazanor^® and Sanorex^®. ⁶ Includes Ritalin^®, other products containing methylphenidate, and products containing dexmethylphenidate. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methamphetamine, Desoxyn^®, or Methedrine¹	4.6	4.7	0.7	0.6	3.4	3.1	5.3	5.5
Prescription Diet Pills²	2.6	2.8	0.4	0.5	1.7^a	2.1	3.0	3.2
Ritalin^® or Methylphenidate	1.9^b	2.3	1.0	1.0	4.9	5.2	1.5^b	2.0
Cylert^®	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
Dexedrine^®	0.7	0.6	0.0	0.1	0.3	0.3	0.9	0.8
Dextroamphetamine	0.3	0.3	0.1	0.1	0.5	0.6	0.3	0.3
Didrex^®	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0
Eskatrol^®	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1
Ionamin^®	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1
Mazanor^®	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Obedrin-LA^®	*	0.0	0.0	0.0	*	*	*	0.0
Plegine^®	0.0	0.0	*	0.0	0.0	0.0	0.0	0.0
Preludin^®	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.2
Sanorex^®	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
Tenuate^®	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0
SELECTED GROUPS OF DRUGS³
Amphetamine, Dextroamphetamine, and Phentermine Products⁴	3.4	3.6	0.8	0.9	3.8^a	4.4	3.7	3.8
Mazindol Products⁵	0.0	0.0	0.0^a	0.1	0.1	0.0	0.0	0.0
Methylphenidate or Dexmethylphenidate Products⁶	1.9^b	2.3	1.0	1.0	4.9	5.2	1.5^b	2.0

130329

Table 1.92A – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Numbers in Thousands, 2011 and 2012
Sedative	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methaqualone, Sopor^®, or Quaalude^®	5,217	5,159	17	24	96^a	56	5,104	5,079
Barbiturates¹	2,055	2,069	22	24	41	37	1,993	2,008
Restoril^® or Temazepam	811^a	1,246	32^a	58	115	140	664	1,047
Amytal^®	251^a	120	7	10	17	10	226	100
Butisol^®	72	164	8	6	20	16	45	142
Chloral Hydrate	122	92	5	7	4	14	113	72
Dalmane^®	340^a	164	5	9	6	19	329^a	136
Halcion^®	327	435	14	10	17	22	296	404
Phenobarbital	755	835	17	22	29	30	709	784
Placidyl^®	526	660	2	4	*	5	524	651
Tuinal^®	696	724	2	3	*	9	693	712
SELECTED GROUPS OF DRUGS²
Temazepam, Flurazepam, or Triazolam³	1,261	1,686	48	69	129	161	1,085	1,455
Any Barbiturates⁴	2,569	2,627	46	58	87	78	2,435	2,491

130329

Table 1.92B – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Percentages, 2011 and 2012
Sedative	Total (2011)	Total (2012)	Aged 12-17 (2011)	Aged 12-17 (2012)	Aged 18-25 (2011)	Aged 18-25 (2012)	Aged 26+ (2011)	Aged 26+ (2012)
*Low precision; no estimate reported. ^a Difference between estimate and 2012 estimate is statistically significant at the 0.05 level. ^b Difference between estimate and 2012 estimate is statistically significant at the 0.01 level. ¹ Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal^®, pentobarbital, Seconal^®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates. ² Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category. ³ Includes Restoril^®, temazepam, Dalmane^®, or Halcion^®. ⁴ Includes barbiturates, Amytal^®, Butisol^®, phenobarbital, and Tuinal^®. Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2011 and 2012.
Methaqualone, Sopor^®, or Quaalude^®	2.0	2.0	0.1	0.1	0.3^a	0.2	2.6	2.5
Barbiturates¹	0.8	0.8	0.1	0.1	0.1	0.1	1.0	1.0
Restoril^® or Temazepam	0.3^a	0.5	0.1^a	0.2	0.3	0.4	0.3	0.5
Amytal^®	0.1^a	0.0	0.0	0.0	0.1	0.0	0.1^a	0.1
Butisol^®	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1
Chloral Hydrate	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0
Dalmane^®	0.1^a	0.1	0.0	0.0	0.0	0.1	0.2^a	0.1
Halcion^®	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.2
Phenobarbital	0.3	0.3	0.1	0.1	0.1	0.1	0.4	0.4
Placidyl^®	0.2	0.3	0.0	0.0	*	0.0	0.3	0.3
Tuinal^®	0.3	0.3	0.0	0.0	*	0.0	0.3	0.4
SELECTED GROUPS OF DRUGS²
Temazepam, Flurazepam, or Triazolam³	0.5	0.6	0.2	0.3	0.4	0.5	0.5	0.7
Any Barbiturates⁴	1.0	1.0	0.2	0.2	0.3	0.2	1.2	1.2